US20070027464A1 - Device for resecting spinal tissue - Google Patents
Device for resecting spinal tissue Download PDFInfo
- Publication number
- US20070027464A1 US20070027464A1 US11/461,036 US46103606A US2007027464A1 US 20070027464 A1 US20070027464 A1 US 20070027464A1 US 46103606 A US46103606 A US 46103606A US 2007027464 A1 US2007027464 A1 US 2007027464A1
- Authority
- US
- United States
- Prior art keywords
- tissue
- cutting head
- inner tubular
- outer sleeve
- arms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1662—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body
- A61B17/1671—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans for particular parts of the body for the spine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/0233—Pointed or sharp biopsy instruments
- A61B10/0266—Pointed or sharp biopsy instruments means for severing sample
- A61B10/0275—Pointed or sharp biopsy instruments means for severing sample with sample notch, e.g. on the side of inner stylet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/16—Bone cutting, breaking or removal means other than saws, e.g. Osteoclasts; Drills or chisels for bones; Trepans
- A61B17/1604—Chisels; Rongeurs; Punches; Stamps
- A61B17/1606—Chisels; Rongeurs; Punches; Stamps of forceps type, i.e. having two jaw elements moving relative to each other
- A61B17/1608—Chisels; Rongeurs; Punches; Stamps of forceps type, i.e. having two jaw elements moving relative to each other the two jaw elements being linked to two elongated shaft elements moving longitudinally relative to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/320016—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/02—Instruments for taking cell samples or for biopsy
- A61B10/06—Biopsy forceps, e.g. with cup-shaped jaws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B17/295—Forceps for use in minimally invasive surgery combined with cutting implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00261—Discectomy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00292—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means
- A61B2017/00336—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery mounted on or guided by flexible, e.g. catheter-like, means with a protective sleeve, e.g. retractable or slidable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00681—Aspects not otherwise provided for
- A61B2017/00685—Archimedes screw
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B2017/0646—Surgical staples, i.e. penetrating the tissue for insertion into cartillege, e.g. meniscus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B2017/0647—Surgical staples, i.e. penetrating the tissue having one single leg, e.g. tacks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B17/2909—Handles
- A61B2017/2911—Handles rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B17/2909—Handles
- A61B2017/2925—Pistol grips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/320016—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
- A61B2017/32004—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes having a laterally movable cutting member at its most distal end which remains within the contours of said end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B2017/320064—Surgical cutting instruments with tissue or sample retaining means
Definitions
- the present invention relates generally to minimally invasive methods, devices and systems for treating spinal disorders using imaging guidance. More particularly, the present invention relates to devices and methods to reduce stenosis and increase the cross-sectional area of the spinal canal available for the spinal cord. Still more particularly, the present invention relates to devices and methods to percutaneously excise portions of an enlarged ligamentum flavum.
- the present invention relates generally to a minimally invasive method, device and system for treating spinal disorders using imaging guidance. More particularly, this invention relates to devices and tools that provide a percutaneous portal to tissues in a region of interest. Still more particularly, this invention relates to devices and tools that provide percutaneous portals to tissue through bone.
- the vertebral column (spine, spinal column, backbone) forms the main part of the axial skeleton, provides a strong yet flexible support for the head and body, and protects the spinal cord disposed in the vertebral canal, which is formed within the vertebral column.
- the vertebral column comprises a stack of vertebrae with an intervertebral disc between adjacent vertebrae. The vertebrae are stabilized by muscles and ligaments that hold the vertebrae in place and limit the movements of the vertebrae.
- each vertebra 10 includes a vertebral body 12 that supports a vertebral arch 14 .
- a median plane 210 generally divides vertebra 10 into two substantially equal lateral sides.
- Vertical body 12 has the general shape of a short cylinder and is anterior to the vertebral arch 14 .
- the vertebral arch 14 together with vertebral body 12 encloses a space termed the vertebral foramen 15 .
- the succession of vertebral foramen 15 in adjacent vertebrae 10 along the vertebral column define the vertebral canal (spinal canal), which contains the spinal cord.
- Vertebral arch 14 is formed by two pedicles 24 which project posteriorly to meet two laminae 16 .
- the two laminae 16 meet posteriomedially to form the spinous process 18 .
- six processes arise.
- Two transverse processes 20 project posterolaterally
- two superior articular processes 22 project generally superiorly and are positioned superior to two inferior articular processes 25 that generally project inferiorly.
- the vertebral foramen 15 is generally an oval shaped space that contains and protects the spinal cord 28 .
- Spinal cord 28 comprises a plurality of nerves 34 surrounded by cerebrospinal fluid (CSF) and an outermost sheath/membrane called the dural sac 32 .
- CSF cerebrospinal fluid
- the CSF filled dural sac 32 containing nerves 34 is relatively compressible.
- Posterior to the spinal cord 28 within vertebral foramen 15 is the ligamentum flavum 26 .
- Laminae 16 of adjacent vertebral arches 14 in the vertebral column are joined by the relatively broad, elastic ligamentum flavum 26 .
- Lumbar spinal stenosis is often defined as a dural sac cross-sectional area less than 100 mm 2 or an anteroposterior (AP) dimension of the canal of less than 10-12 mm for an average male.
- AP anteroposterior
- the source of many cases of lumbar spinal stenosis is thickening of the ligamentum flavum.
- Spinal stenosis may also be caused by subluxation, facet joint hypertrophy, osteophyte formation, underdevelopment of spinal canal, spondylosis deformans, degenerative intervertebral discs, degenerative spondylolisthesis, degenerative arthritis, ossification of the vertebral accessory ligaments and the like.
- a less common cause of spinal stenosis which usually affects patients with morbid obesity or patients on oral corticosteroids, is excess fat in the epidural space.
- the excessive epidural fat compresses the dural sac, nerve roots and blood vessels contained therein and resulting in back and leg pain and weakness and numbness of the legs.
- Spinal stenosis may also affect the cervical and, less commonly, the thoracic spine.
- an incision is made in the back and the muscles and supporting structures are stripped away from the spine, exposing the posterior aspect of the vertebral column.
- the thickened ligamentum flavum is then exposed by removal of a portion of the vertebral arch, often at the laminae, covering the back of the spinal canal (laminectomy).
- the thickened ligamentum flavum ligament can then be excised by sharp dissection with a scalpel or punching instruments such as a Kerison punch that is used to remove small chips of tissue.
- the procedure is performed under general anesthesia. Patients are usually admitted to the hospital for approximately five to seven days depending on the age and overall condition of the patient. Patients usually require between six weeks and three months to recover from the procedure. Further, many patients need extended therapy at a rehabilitation facility to regain enough mobility to live independently.
- Minimally invasive techniques offer the potential for less post-operative pain and faster recovery compared to traditional open surgery.
- Percutaneous interventional spinal procedures can be performed with local anesthesia, thereby sparing the patient the risks and recovery time required with general anesthesia.
- Microdiscectomy is performed by making a small incision in the skin and deep tissues to create a portal to the spine. A microscope is then used to aid in the dissection of the adjacent structures prior to discectomy. The recovery for this procedure is much shorter than traditional open discectomies.
- Percutaneous discectomy devices with fluoroscopic guidance have been used successfully to treat disorders of the disc but not to treat spinal stenosis or the ligamentum flavum directly.
- Arthroscopy or direct visualization of the spinal structures using a catheter or optical system have also been proposed to treat disorders of the spine including spinal stenosis, however these devices still use miniaturized standard surgical instruments and direct visualization of the spine similar to open surgical procedures. These devices and techniques are limited by the small size of the canal and these operations are difficult to perform and master. In addition, these procedures are painful and often require general anesthesia. Further, the arthroscopy procedures are time consuming and the fiber optic systems are expensive to purchase and maintain.
- any surgery regardless of whether open or percutaneous, includes a risk of damage to the nerves of the spinal cord.
- the device comprises an outer sleeve.
- the device comprises an inner tubular member slidingly received within the outer sleeve.
- the device comprises a cutting head connected to a distal end of the inner tubular, wherein the cutting head comprises at least three arms extending axially from the inner tubular.
- the device has an open position in which the cutting head extends from the outer sleeve, and a closed position in which the cutting head is at least partially disposed within the sleeve.
- the method comprises the step of positioning a tissue excision device adjacent the region of interest, wherein the tissue excision device comprises an outer sleeve, an inner tubular member slidingly received within the outer sleeve, and a cutting head connected to a distal end of the inner tubular, the cutting head including at least three arms extending axially from the inner tubular.
- the method comprises the step of opening the tissue excision device by extending the cutting head from the outer sleeve. Further, the method comprises the step of inserting the tissue excision device into tissue in the region of interest. Still further, the method comprises the step of closing the tissue excision device by advancing the outer sleeve over the cutting head. Moreover, the method comprises the step of retracting the tissue excision device from the tissue in the region of interest.
- kits for performing a procedure on a spine including an epidural space containing a dural sac.
- the kit comprises an insertion member for accessing the epidural space.
- the kit comprises a volume of a contrast medium adapted to be inserted into the epidural space by the insertion member and expanded so as to compress a portion of the thecal sac and provide a safety zone within the epidural space.
- the kit comprises a tissue excision device comprising an outer sleeve, an inner tubular member slidingly received within the outer sleeve, a cutting head connected to a distal end of the inner tubular, wherein the cutting head comprises at least three arms extending axially from the inner tubular.
- FIG. 1 is cross-section of the spine viewed from the space between two vertebrae, showing the upper surface of one vertebra and the spinal canal with the dural sac and a normal (un-stenosed) ligamentum flavum therein;
- FIG. 2 is an illustration of the same section as FIG. 1 , showing the spinal canal with the dural sac and a thickened ligamentum flavum therein;
- FIG. 3 is an enlarged cross-section of a vertebral foramen, showing a safety zone created by compression of the dural sac;
- FIG. 4 is the cross-section of FIG. 3 , showing a tissue excision tool positioned in the ligamentum flavum;
- FIGS. 5-9 are a series of illustrations showing tissue excision by a tissue-excision tool constructed in accordance with a first embodiment of the invention.
- FIGS. 10-14 are a series of illustrations showing tissue excision by a tissue-excision tool constructed in accordance with a second embodiment of the invention.
- FIGS. 15 and 17 are sequential illustrations showing removal of tissue from a tissue-excision tool by a tissue-removal device constructed in accordance with an embodiment of the invention
- FIGS. 16 and 18 are end views of the tissue-removal device of FIGS. 15 and 17 , respectively;
- FIG. 19 shows an alternative embodiment of a grasping needle with a corkscrew shape
- FIG. 20 is a perspective view of a tissue-excision tool constructed in accordance with a third embodiment of the invention.
- FIGS. 21 and 22 are enlarged cross-sectional and perspective views, respectively, of the grasping device of FIG. 20 in its retracted position;
- FIGS. 23 and 24 are enlarged cross-sectional and perspective views, respectively, of the grasping device of FIG. 20 in its extended position;
- FIG. 25 is a schematic illustration of one embodiment of a double-ended ligament anchor being deployed in a ligamentum flavum
- FIG. 26 shows the device of FIG. 25 after full deployment
- FIG. 27 is a perspective view of an entire tool constructed in accordance with preferred embodiments.
- FIG. 28 is an enlarged cross-sectional view of the distal tip of the tool of FIG. 27 with the aperture partially opened;
- FIG. 29 is a cross-sectional view of the handle end of the tool of FIG. 27 ;
- FIG. 30 is cross-section of another embodiment of a tissue-removal device
- FIG. 31 is a perspective view of the distal portion of an embodiment of a tissue excision device in an open position
- FIG. 32 is an end-view of the tissue excision device of FIG. 31 ;
- FIG. 33 is a perspective view of the tissue excision device of FIG. 31 transitioning from the open position to the closed position;
- FIGS. 34 and 35 are sequential schematic illustrations showing the excision of tissue by the tissue excision tool illustrated in FIG. 31 .
- the x-, y-, and z-axes are shown in FIGS. 1 and 3 to aid in understanding the descriptions that follow.
- the x-, y-, and z-axes have been assigned as follows.
- the x-axis is perpendicular to the longitudinal axis of the vertebral column and perpendicular to the coronal/frontal plane (i.e., x-axis defines anterior vs. posterior relationships).
- the y-axis runs substantially parallel to the vertebral column and perpendicular to the transverse plane (i.e., y-axis defines superior vs. inferior relationships).
- the z-axis is perpendicular to the longitudinal axis of the vertebral column and perpendicular to the median/midsagittal plane (i.e., z-axis defines the lateral right and left sides of body parts).
- the set of coordinate axes (x-, y-, and z-axes) are consistently maintained throughout although different views of vertebrae and the spinal column may be presented.
- the median/midsagittal plane passes from the top to the bottom of the body and separates the left and the right sides of the body, and the spine, into substantially equal halves (e.g., two substantially equal lateral sides).
- the frontal/coronal plane essentially separates the body into the forward (anterior) half and the back (posterior) half, and is perpendicular to the median plane.
- the transverse plane is perpendicular to both the median plane and coronal plane and is the plane which divides the body into an upper and a lower half.
- vertebral foramen 15 contains a portion of the ligamentum flavum 26 , spinal cord 28 , and an epidural space 27 between ligamentum flavum 26 and spinal cord 28 .
- Spinal cord 28 comprises a plurality of nerves 34 surrounded by cerebrospinal fluid (CSF) contained within dural sac 32 .
- Nerves 34 normally comprise only a small proportion of the dural sac 32 volume.
- CSF filled dural sac 32 is somewhat locally compressible, as localized pressure causes the CSF to flow to adjacent portions of the dural sac.
- Epidural space 27 is typically filled with blood vessels and fat.
- the posterior border of the normal epidural space 27 generally defined by the ligamentum flavum 26 , which is shown in its normal, non-thickened state in FIG. 1 .
- FIG. 2 illustrates a case of spinal stenosis resulting from a thickened ligamentum flavum 26 .
- vertebral foramen 15 is defined and surrounded by the relatively rigid bone its volume is substantially constant.
- thickening of ligamentum flavum 26 within vertebral foramen 15 can eventually result in compression of spinal cord 28 .
- the thickened ligamentum flavum 26 may exert a compressive force on the posterior surface of dural sleeve 32 .
- thickening of ligamentum flavum 26 may compress the blood vessels and fat occupying epidural space 27 .
- Compression of spinal cord 28 may result in low back pain as well as pain or abnormal sensations in the legs. Further, compression of the blood vessels in the epidural space 27 that houses the nerves of the cauda equina may result in ischemic pain termed spinal claudication.
- a thickened or enlarged ligamentum flavum 26 In order to relieve the symptoms associated with a thickened or enlarged ligamentum flavum 26 , methods, techniques, and devices described herein may be employed to reduce the compressive forces exerted by the thickened ligamentum flavum on spinal cord 28 and the blood vessels in epidural space 27 (ergo, decompress spinal cord 28 and blood vessels in epidural space 27 ).
- compressive forces exerted by the thickened/enlarged ligamentum flavum 26 may be reduced by embodiments of a minimally invasive ligament decompression (MILD) procedure described herein.
- the MILD procedure may be performed percutaneously to reduce the size of ligamentum flavum 26 by excising portions of ligamentum flavum 26 .
- the ligamentum flavum 26 is accessed, cut and removed ipsilaterally (i.e., on the same side of vertebral arch 14 ) by a percutaneous cranial-caudal approach.
- ILAMP Ipsilateral Approach MILD Procedure
- ligamentum flavum 26 is posteriorly apposed to spinal cord 28 .
- placement of tools within ligamentum flavum 26 to excise portions of ligamentum flavum 26 creates a risk of for inadvertent damage to the spinal cord 28 , dural sac 32 , and/or nerves 34 .
- a gap is advantageously created between ligamentum flavum 26 and spinal cold 28 to provide a safety zone between ligamentum flavum 26 and spinal cord 28 .
- FIG. 3 illustrates an enlarged cross-sectional view of a vertebral foramen 15 within a vertebra.
- Vertebral foramen 15 includes epidural space 27 and spinal cord 28 containing nerves 34 and CSF within dural sac 32 .
- a thickened/enlarged ligamentum flavum 26 extends into vertebral foramen 15 .
- a safety zone 40 is created between ligamentum flavum 26 and dural sac 32 .
- spinal cord 28 comprises nerves 34 surrounded by CSF and is contained within dural sac 32 . Since more than 90% of the volume of dural sac 32 in the lumbar region is filled by CSF, dural sac 32 is highly compressible. Thus, even when stenosis is causing compression of spinal cord 28 , in most cases it is possible to temporarily compress spinal cord 28 further. Thus, according to preferred embodiments, dural sac 32 is further compressed in the region of interest by injecting a fluid into epidural space 27 to create safety zone 40 .
- safety zone 40 The presence of the injected fluid comprising safety zone 40 gently applies an additional compressive force to the outer surface of dural sac 32 so that at least a portion of the CSF within dural sac 32 is forced out of dural sac 32 in the region of interest, resulting in safety zone 40 between dural sac 32 and ligamentum flavum 26 .
- dural sac 32 is compressed by injecting a standard radio-opaque non-ionic myelographic contrast medium or other imagable or non-imagable medium into epidural space 27 in the region of interest. This is preferably accomplished with a percutaneous injection. Sufficient injectable fluid is preferably injected to displace the CSF out of the region of interest and compress dural sac 32 to at least a desired degree. The injected medium is preferably substantially contained within the confines of epidural space 27 extending to the margins of the dural sac 32 .
- the epidural space is substantially watertight and the fatty tissues and vascularization in epidural space 27 , combined with the viscous properties of the preferred fluids, serve to substantially maintain the injected medium in the desired region of interest.
- This novel method for protecting spinal cord 28 column may be referred to hereinafter as “contrast-guided dural protection.”
- a tool 100 such as the tissue excision devices and tissue retraction devices described below, may be inserted into the ligamentum flavum 26 , as illustrated in FIG. 4 .
- Tool 100 may comprise any suitable device, tool, or instrument for relieving stenosis caused by the thickened/enlarged ligamentum flavum 26 including without limitation, embodiments of tissue excision devices and tissue retraction devices described in more detail below.
- tool 100 is positioned in the ligamentum flavum 26 on the opposite side of median plane 210 as tool 100 percutaneously accesses the body, such that tool 100 crosses median plane 210 .
- tool 100 is inserted and positioned in the ligamentum flavum 26 on the same side (ipsilateral) of median plane 210 as tool 100 percutaneously accesses the body, such that tool 100 does not cross median plane 210 .
- the presence of safety zone 40 reduces the likelihood that dural sac 32 will be damaged, even if the tool breaks through the anterior surface of ligamentum flavum 26 .
- a fluoroscopic window of access is defined by the inferior margin of the lamina (contra lateral to the point of instrument entry in the soft tissues) and the dorsal margin of the contrast material that defines the epidural space.
- This FWA is roughly orthogonal to the long axis of the cutting instrument, which parallels the inferior surface of the lamina as in FIG. 4 .
- the fluoroscopic plane of projection is preferably but not necessarily oriented 20-40 degrees from normal (AP projection).
- the spine can be imaged using any suitable technology, including without limitation, 2D fluoroscopy, 3D fluoroscopy, CT, MRI, ultrasound or with direct visualization with fiber optic or microsurgical techniques. Stereotactic or computerized image fusion techniques are also suitable. Fluoroscopy is currently particularly well-suited to the techniques disclosed herein. Fluoroscopic equipment is safe and easy to use, readily available in most medical facilities, relatively inexpensive. In a typical procedure, using direct biplane fluoroscopic guidance and local anesthesia, epidural space 27 is accessed for injection of contrast media adjacent to the surgical site.
- the safety zone created by the present contrast-guided dural compression techniques can reduce the risk of damage to the spinal cord during procedures to remove or displace portions of the ligamentum flavum and/or laminae in order to treat spinal stenosis.
- the injected medium can be provided as a re-absorbable water-soluble gel, so as to better localize safety zone 40 at the site of surgery and reduce leakage of this protective layer from the vertebral/spinal canal.
- An injectable gel is a significant improvement on prior epidural injection techniques.
- the gel is preferably substantially more viscid than conventional contrast media and the relatively viscid and/or viscous gel preferably tends to remain localized at the desired site of treatment as it does not spread as much as standard liquid contrast media that are used in epidurography. This may result in more uniform compression of dural sac 32 and less leakage of contrast out of the vertebral/spinal canal.
- preferred embodiments of the gel are re-absorbed more slowly than conventional contrast media, allowing for better visualization during the course of the surgical procedure.
- a contrast agent can be included in the gel itself, so that the entire gel mass is imagable.
- an amount of contrast can be injected first, followed by the desired amount of gel, or an amount of gel can be injected first, followed by the desired amount of contrast.
- the contrast agent is captured on the surface of the expanding gel mass, so that the periphery of the mass is imagable.
- any standard hydrophilic-lipophilic block copolymer (Pluronic) gel such as are known in the art would be suitable and other gels may be used as the injectable medium.
- the gel preferably has an inert base.
- the gel material is liquid at ambient temperatures and can be injected through a small bore (such as a 27 gauge needle).
- the gel then preferably becomes viscous when warmed to body temperature after being injected.
- the viscosity of the gel can be adjusted through the specifics of the preparation.
- the gel or other fluid is preferably sufficiently viscid or viscous at body temperature to compress and protect the thecal sac in the manner described above and to remain sufficiently present in the region of interest for at least about 30 minutes.
- the injected gel attains a viscosity that is two, three, six or even ten times that of the fluids that are typically used for epidurograms.
- the injected medium undergoes a reversible change in viscosity when warmed to body temperature so that it can be injected as a low-viscosity fluid, thicken upon injection into the patient, and be returned to its low-viscosity state by cooling.
- the injected medium is injected as desired and thickens upon warming, but can be removed by contacting it with a heat removal device, such as an aspirator that has been provided with a cooled tip.
- a heat removal device such as an aspirator that has been provided with a cooled tip.
- a suitable contrast medium having the desired properties is Omnipaque® 240 available from Nycomed, New York, which is a commercially available non-ionic iodinated myelographic contrast medium.
- Other suitable injectable media will be known to those skilled in the art. Because of the proximity to spinal cord 28 and spinal nerves 34 , it is preferred not to use ionic media in the injectable medium. The preferred compositions are reabsorbed relatively rapidly after the procedure. Thus any residual gel compression on dural sac 32 after the MILD procedure dissipates relatively quickly. For example, in preferred embodiments, the gel would have sufficient viscosity to compress dural sac 32 for thirty minutes, and sufficient degradability to be substantially reabsorbed within approximately two hours.
- the injected contrast medium further may further include one or more bioactive agents.
- bioactive agents such as those used in epidural steroid injection (e.g. Depo medrol, Celestone Soluspan) may be added to the epidural gel to speed healing and reduce inflammation, scarring and adhesions.
- the gel preferably releases the steroid medication slowly and prolongs the anti-inflammatory effect, which can be extremely advantageous.
- Local anesthetic agents may also be added to the gel. This prolongs the duration of action of local anesthetic agents in the epidural space to prolong pain relief during epidural anesthesia.
- the gel may be formulated to slow the reabsorption of the gel.
- the present gels may also be used for epidural steroid injection and perineural blocks for management of acute and chronic spinal pain.
- Thrombin or other haemostatic agents can be added if desired, so as to reduce the risk of bleeding.
- the gel may also be used as a substitute for a blood patch if a CSF leak occurs.
- the gel may also be used as an alternative method to treat lumbar puncture complications such as post-lumbar puncture CSF leak or other causes of intracranial hypotension.
- the gel may be used to patch postoperative CSF leaks or dural tears. If the dural sac were inadvertently torn or cut, then gel could immediately serve to seal the site and prevent leakage of the cerebral spinal fluid.
- the margins of epidural space 27 are clearly demarcated by the injected medium and can be visualized radiographically if an imagable medium has been used.
- percutaneous procedures can now safely be performed on ligamentum flavum 26 and/or surrounding tissues without injuring dural sac 32 or nerves 34 and the spinal canal can be decompressed using any of several techniques. Suitable decompression techniques include removal of tissue from the ligamentum flavum, laminectomy, laminotomy, and ligament retraction and anchoring.
- ligamentum flavum 26 and/or lamina 16 are excised using a percutaneous tissue excision device or probe 100 , which may hereinafter be referred to as the MILD device.
- a percutaneous tissue excision device or probe 100 As shown schematically in FIG. 4 , a device 100 may be placed parallel to the posterior and lateral margin of the safety zone 40 with its tip in the ligamentum flavum 26 .
- Preferred embodiments of the present tissue excision devices and techniques can take several forms.
- the distal ends of the tools are described in detail.
- the construction of the proximal ends of the tools, and the means by which the various components disclosed herein are assembled and actuated, will be known and understood by those skilled in the art.
- device 100 maybe a coaxial excision system 50 with a sharpened or blunt tip that is placed obliquely into the thickened ligamentum flavum 26 posterior to safety zone 40 under fluoroscopic guidance.
- the needle is preferably placed parallel to the posterior margin of the canal.
- Excision system 50 is preferably manufactured from stainless steel, titanium or other suitable durable biocompatible material.
- an outer needle or cannula 51 has an opening or aperture 52 on one side that is closed during insertion by an inner occluding member 54 . Aperture 52 is readily visible under imaging guidance.
- inner occluding member 54 is removed or retracted so that it no longer closes aperture 52 ( FIG. 6 ).
- Aperture 52 is preferably oriented away from the epidural space so as to further protect the underlying structures from injury during the surgical procedure. If it was not already present in the tool, a tissue-engaging means 56 is inserted through outer needle 51 to aperture 52 so that it contacts adjacent tissue, e.g., the ligamentum flavum, via aperture 52 .
- Tissue-engaging means 56 may be a needle, hook, blade, tooth or the like, and preferably has at least one flexible barb or hook 58 attached to its shaft.
- the barb 58 or barbs may extend around approximately 120 degrees of the circumference of the shaft.
- Barbs 58 are preferably directed towards the proximal end of the tool.
- tissue-engaging means 56 When tissue-engaging means 56 is retracted slightly, barbs 58 allow it to engage a segment of tissue.
- the tissue sample engaged by tissue-engaging means 56 may be generally cylindrical or approximately hemispherical.
- inner occluding means 54 which is preferably provided with a sharpened distal edge, is advanced so that it cuts the engaged tissue section or sample loose from the surrounding tissue.
- occluding means 54 also functions as a cutting means in this embodiment.
- a cylindrical outer cutting element 60 may extended over outer needle 51 and used in place of occluding member 54 to excise the tissue sample.
- tissue-engaging needle 56 can be pulled back through outer needle 51 so that the segment of tissue can be retrieved and removed from the barbs ( FIG. 8 ). The process or engaging and resecting tissue may be repeated ( FIG. 9 ) until the canal is adequately decompressed.
- a tissue-engaging hook 64 can be used in place of needle 56 and an outer cutting member 60 can be used in place of inner occluding member 54 .
- Hook 64 may comprise a length of wire that has been bent through at least about 270°, more preferably through 315°, and still more preferably through about 405°.
- hook 64 may comprise NitinolTM, or any other resilient metal that can withstand repeated elastic deflections.
- hook 64 includes at least one barb 58 at its distal end.
- hook 64 is pre-configured in a curvilinear shape and is retained within tool 100 by outer cutting member 60 .
- hook 64 When cutting member 60 is retracted, the curved shape of hook 64 urges its outer end to extend outward through aperture 52 . If desired, hook 64 can be advanced toward the distal end of tool 100 , causing it to extend farther into the surrounding tissue. In some embodiments, hook 64 is provided with a camming surface 66 . Camming surface 66 beats on the edge of opening 52 as hook 64 is advance or retracted and thereby facilitates retraction and retention of hook 64 as it is retracted into the tool. In these embodiments, hook 64 may not extend through aperture 52 until it has been advanced sufficiently for camming surface 66 to clear the edge of the opening. Hook 64 may alternatively be used in conjunction with an inner occluding member 54 in the manner described above. As above, hook 64 can be used to retrieve the engaged tissue from the distal end of the tool.
- the tissue-engaging means may comprise a hook or tooth or the like that engages tissue via aperture 52 by being rotated about the tool axis.
- the tissue-engaging means could comprise a partial cylinder that is received in outer cannula 51 and has a serrated side edge. Such a device can be rotated via a connection with the tool handle or other proximal device. As the serrated edge traverses aperture 52 tissue protruding into the tool via the aperture is engaged by the edge, whereupon it can be resected and retrieved in the manner disclosed herein.
- the working tip of tool 100 remains within the ligamentum flavum and does not penetrate the safety zone 40 . Nonetheless, safety zone 40 is provided so that even an inadvertent penetration of the tool into the epidural space will not result in damage to the thecal sac.
- tissue-removal device such as that described below is preferably used to remove the tissue from the retrieval device between each excision.
- Each piece of tissue may be removed from barbs 58 by pushing tissue-engaging means 56 through an opening that is large enough to allow passage of the flexible barbs and supporting needle but smaller than the diameter of the excised tissue mass. This pushes the tissue up onto the shaft, where it can be removed with a slicing blade or the like or by sliding the tissue over the proximal end of the needle.
- needle 56 can be removed and re-inserted into the tool for external, manual tissue removal.
- approximately 8-10 cores or segments of tissue will be excised and pushed up the shaft towards the hub during the course of the procedure.
- a small blade can be used to split the tissue segment and thereby ease removal of the segment from the device.
- a blade for this purpose can be placed on the shaft of needle 56 proximal to the barbs.
- the tissue removal device may include a scraper 120 that includes a keyhole slot having a wide end 122 and a narrow end 124 .
- the tissue-engaging device with a mass of excised tissue 110 thereon can be retracted (pulled toward the proximal end of the tool) through wide end 122 of the slot and then re-inserted (pushed toward the distal end of the tool) through narrow end 124 of the slot.
- Narrow end 124 is large enough to allow passage of the barbed needle, but small enough to remove the tissue mass as the needle passes through.
- the removed tissue can exit the tool through an opening 113 in the tool body.
- the tissue removal device may be constructed such that tissue is removed from the tissue-engaging device by retracting the tissue-engaging device through narrow end 124 of the slot.
- narrow end 124 is large enough to allow passage of the shaft of the tissue-engaging device, but small enough to remove the tissue mass as the needle passes through.
- the tissue-engaging device is constructed of a tough material, the barbs or the like will cut through the tissue and/or deform and release the tissue.
- the removed tissue can exit the tool through an opening 113 in the tool body.
- an alternative mechanism for removing the tissue segment from needle 56 includes an adjustable aperture in a disc. After the tissue-bearing needle is pulled back through the aperture, the aperture is partially closed. Needle 56 and flexible hooks 58 then can pass through the partially closed aperture but the larger cylinder of tissue cannot. Thus the tissue segment is pushed back onto the shaft. The tissue segment can either be pulled off the proximal end of the shaft or cut off of it. A small blade may be placed just proximal to the barbs to help cut the tissue segment off the shaft.
- the variable aperture can formed by any suitable construction, including a pair of metal plates with matching edges that each define one half of a central opening. The two pieces may be held apart by springs. The aperture may be closed by pushing the two edges together. In other embodiments, this process can be mechanically automated by using a disc or plate with an opening that is adjustable by a variety of known techniques, including a slit screw assembly or flexible gaskets.
- embodiments of the grasping mechanism include but are not limited to: needles with flexible barbs, needles with rigid barbs, corkscrew-shaped needles, and/or retaining wires.
- the corkscrew-shaped needle shown in FIG. 19 works by screwing into the ligamentum flavum in the manner that a corkscrew is inserted in a cork. After the screw engages a segment of tissue, outer cutting element 60 slides over the needle, cutting a segment of tissue in a manner similar to that of the previous embodiment. In some embodiments, the cutting element can be rotated as it cuts.
- cannulated scalpel 51 houses a grasping device 70 that includes at least one pair of arcuate, closable arms 72 .
- Closable arms 72 may be constructed in any suitable manner.
- One technique for creating closable arms is to provide a slotted sleeve 74 , as shown.
- Slotted member 74 preferably comprises an elongate body 75 with at least one slot 76 that extends through its thickness but does not extend to either end of the body. Slot 76 is preferably parallel to the longitudinal axis of the sleeve.
- a strip 77 is defined, with strips 77 being joined at each end of sleeve 74 .
- each strip 77 be relatively small. In some embodiments, it may be desirable to construct slotted member 74 from a portion of a hollow tube or from a rectangular piece that has been curved around a longitudinal axis. The inner edge of each strip that lies along slot 76 forms an opposing edge 78 . The width of the piece is the total of the width of strips 77 and slot 76 .
- each strip 77 Advancing one end of sleeve 74 toward the other end of sleeve 74 causes each strip 77 to buckle or bend. If strips 77 are prevented from buckling inward or if they are predisposed to bend in the desired direction, they will bend outward, thereby forming arcuate arms 72 , which extend through aperture 52 of cannulated scalpel 51 , as shown in FIG. 21 . As they move away from the axis of body 75 , arms 72 move apart in a direction normal to the axis of body 75 . Likewise, moving the ends of sleeve 74 apart causes arms 72 to straighten and to move together and inward toward the axis of the device, as shown in FIG. 22 . As the arms straighten, opposing edges 78 close and a segment of tissue can be capture between them. Tissue within the grasping device may then be resected or anchored via the other mechanisms described herein.
- Closable arms 72 may include on their opposing edges 78 ridges, teeth, or other means to facilitate grasping of the tissue. In other embodiments, edges 78 may be sharpened, so as to excise a segment of tissue as they close. In these embodiments, closable arms 72 may also be used in conjunction with a hook, barbed needle, pincers or the like, which can in turn be used to retrieve the excised segment from the device.
- the tissue can be excised using a blade such as cutting element 60 above.
- the excised tissue can be removed from the inside of needle 51 using a tissue-engaging hook 64 or other suitable means.
- the process of extending and closing arms 72 , excising the tissue, and removing it from the device can be repeated until a desired amount of tissue has been removed.
- this cycle can be repeated without repositioning the device in the tissue.
- the tool can be rotated or repositioned as desired between excisions. It is possible to rotate or reposition the tool during an excision, but it is expected that this will not generally be preferred. Furthermore, it is expected that the steps of tissue excision and removal can be accomplished without breaching the surface of the ligament, i.e. without any part of the device entering the safety zone created by the injected fluid. Nonetheless, should the tool leave the working zone, the safety zone will reduce the risk of injury to the thecal sac.
- the spinal canal may also be enlarged by retracting the ligamentum flavum, either with or without concurrent resection.
- Retraction is preferably but not necessarily performed after dural compression has been used to provide a safety zone.
- the dural compression techniques described above have the effect of pressing the ligamentum flavum back out of the spinal canal and thereby making it easier to apply a restraining means thereto.
- a retraction device 90 as shown in FIG. 23 is used to retract and compress the thickened soft tissues around the posterior aspect of the spinal canal, thereby increasing the available space for the dural sac and nerves.
- retraction device 90 is a double-headed anchor that includes at least one distal retractable tissue-engaging member 91 and at least one proximal tissue-engaging member 92 , each of which are supported on a body 94 .
- Retraction device 90 is preferably constructed from an implantable, non-biodegradable material, such as titanium or stainless steel, but may alternatively be polymeric or any other, suitable material.
- body 94 is somewhat flexible.
- barbs 91 , 92 may comprise hooks, arms, teeth, clamps, or any other device capable of selectively engaging adjacent tissue. Barbs 91 , 92 may have any configuration that allows them to engage the ligamentum flavum and/or surrounding tissue. Similarly, barbs 91 , 92 may be covered, sheathed, pivotable, retractable, or otherwise able to be extended from a first position in which they do not engage adjacent tissue to a second position in which they can engage adjacent tissue.
- FIG. 23 shows schematically the distal and proximal retractable arms 91 , 92 of a preferred ligament anchor 90 .
- the proximal end of the anchor preferably includes a threaded connector 96 or other releasable mechanism that attaches to a support rod 100 .
- Ligament anchor 90 may be attached to a support shaft 112 and sheathed in a guide housing 114 .
- the distal and proximal barbs 91 , 92 are prevented by guide housing 114 from engaging surrounding tissue.
- Housing 102 is preferably a metal or durable plastic guide housing.
- the distal end of the device is preferably positioned in the ligamentum flavum under fluoroscopic guidance. If desired, an accessway through the lamina may be provided using an anchored cannula or the like.
- the device is held in position by support shaft 112 .
- Distal barbs 91 are unsheathed and optionally expanded by pulling back guide housing 102 , as shown in FIG. 23 .
- Distal barbs 91 are secured in the ligamentum flavum by pulling back on the support shaft 112 . With barbs 91 engaging the tissue, the ligamentum flavum is retracted posteriorly by pulling back on support shaft 112 .
- proximal barbs 92 are uncovered and expanded by retracting guide housing 114 , as shown in FIG. 24 .
- Barbs 92 are preferably positioned in the soft tissues 116 in the para-spinal region so that the device is firmly anchored behind the posterior elements of the spinal canal.
- support shaft 112 may be detached from body 94 as shown in FIG. 24 .
- the posterior margin 95 of the ligamentum flavum can be held in a retracted position, thereby expanding the canal. The procedure can then be repeated on adjacent portions of the ligamentum flavum until it is sufficiently retracted.
- proximal end of ligament anchor 90 may be adapted to engage the lamina. This may be accomplished by having the arm posterior to the lamina or by using the laminotomy and suturing the device to the lamina there. A knotted or knotless system or a suture plate can be used.
- a second embodiment of the present method uses a plurality of retraction devices 90 .
- the retraction device is inserted through one lamina in an oblique fashion, paralleling the opposite lamina. After the distal anchor is deployed, the retraction device is pulled back and across the ligamentum flavum, thereby decompressing the opposite lateral recess of the spinal canal. This is repeated on the opposite side.
- This same device can also be deployed with a direct approach to the lateral recess with a curved guide housing.
- retraction device 90 is describe above as a double-headed anchor, it will be understood that other devices can be used.
- sutures, barbed sutures, staples or the like can be used to fasten the ligament in a retracted position that reduces stenosis.
- a dural sac cross-sectional area less than 100 mm 2 or an anteroposterior (AP) dimension of the canal of less than 10-12 mm in an average male is typically considered relative spinal stenosis.
- a dural sac cross-sectional area less than 85 mm 2 in an average male is considered severe spinal stenosis.
- the present devices and techniques are anticipated to cause an increase in canal area of 25 mm 2 per anchor or 50 mm 2 total.
- the cross-sectional area of the dural sac can be increased by 10 mm 2 , and in some instances by as much as 20 mm 2 or even 30 mm 2 .
- the present invention can result in an increase of the anteroposterior dimension of the canal by 1 to 2 mm and in some instances by as much as 4 or 6 mm.
- the actual amount by which the cross-sectional area of the thecal sac and/or the anteroposterior dimension of the canal are increased will depend on the size and age of the patient and the degree of stenosis and can be adjusted by the degree of retraction of the ligament.
- the minimally invasive ligament decompression (MILD) devices and techniques described herein allow spinal decompression to be performed percutaneously, avoiding the pain and risk associated with open surgery. Through the provision of a safety zone, the present devices and techniques offer reduced risk of spinal cord damage. In addition to improving nerve function, it is expected that decompression of the spinal canal in the manner described herein will result in improved blood flow to the neural elements by reducing the extrinsic pressure on the spinal vasculature. For these reasons, it is believed that spinal decompression performed according to the present invention will be preferable to decompression operations performed using currently known techniques.
- a mechanical device such as a balloon or mechanical shield can also be used to create a protective guard or barrier between the borders of the epidural space and the adjacent structures.
- a durable expandable device is attached to the outside of the percutaneous laminectomy device, preferably on the side opposite the cutting aperture. The cutting device is inserted into the ligamentum flavum with the expandable device deflated. With the aperture directed away from the spinal canal, the expandable device is gently expanded via mechanical means or inflated with air or another sterile fluid, such as saline solution, via a lumen that may be within or adjacent to the body of the device. This pushes the adjacent vital structures clear from the cutting aperture of the device and simultaneously presses the cutting aperture into the ligament.
- the grasping and cutting needles can then be deployed and operated as desired.
- the balloon does not interfere with tissue excision because it is located on the side opposite the cutting aperture.
- the cutting needle may be hemispherical (semi-tubular) in shape with either a straight cutting or a sawing/reciprocating blade or may be sized to be placed within the outer housing that separates the balloon from the cutting aperture.
- a self-expanding metal mesh is positioned percutaneously in the epidural space.
- a guide catheter is placed in the epidural space at the site of the intended surgical procedure.
- the mesh is preferably compressed within a guide catheter.
- the mesh expands in the epidural space, protecting and displacing the adjacent dural sheath.
- the mesh is pulled back into the guide sheath and the assembly removed.
- the mesh is deformable and compresses as it is pulled back into the guide catheter, in a manner similar to a self-expanding mesh stent.
- self-expanding stents There are many commercially available self-expanding stents approved and in use in other applications. However, using a self-expandable mesh as a device within the epidural space to protect and displace the thecal sac is novel.
- Embodiments of tissue excision tools, devices, and methods disclosed herein may take several forms and may be used in accordance with the MILD method described above, or used according to alternative procedures such as the ipsilateral approach minimally invasive ligament decompression procedure (ILAMP method) disclosed in U.S. application Ser. No. 11/382,349, which is hereby incorporated herein by reference in its entirety.
- ILAMP method minimally invasive ligament decompression procedure
- tissue excision devices In the descriptions of the tissue excision devices below, the distal portions of the devices are described in detail, distal referring to positions that are relatively closer to the region of interest (e.g., the thickened portion of the ligamentum flavum to be decompressed).
- An exemplary embodiment of a proximal end for the tissue excision devices, including an actuation means, is also described below.
- embodiments of tissue extraction devices described herein may be used with a variety of proximal ends and a variety of actuation means that are known and understood by those skilled in the art.
- FIGS. 31-33 illustrate the distal portion of an embodiment of a tissue excision device 200 in an open position.
- Tissue excision device 200 comprises an inner tubular 230 coaxially disposed within and slidingly engaging an outer sleeve 210 .
- Inner tubular 230 and sleeve 210 both share a central longitudinal axis 250 .
- Sleeve 210 has an inner radius R 1 (not shown), as measured from axis 250
- inner tubular 230 has an outer radius R 2 (not shown), as measured from axis 250 .
- outer radius R 2 is substantially the same or slightly less than inner radius R 1 such that the outer surface of inner tubular 230 slidingly engages the inner surface of sleeve 210 .
- Sleeve 210 and inner tubular 230 are permitted to move axially (i.e., along axis 250 ) relative to each other.
- Sleeve 210 and inner tubular 230 may be formed from any suitable hollow bodies including without limitation a hypotube, cannula, or catheter.
- sleeve 210 and inner tubular 230 shown in FIGS. 31-33 generally have a circular cross-section, in general sleeve 210 and inner tubular 230 may have any suitable shape and cross-section including without limitation circular, oval, or rectangular.
- Inner tubular 230 includes a central cavity or through bore 240 ( FIG. 32 ) that runs the length of inner tubular 230 .
- a cutting head 250 is disposed at the distal end of inner tubular 230 .
- cutting head 250 is formed integrally with inner tubular 230 such as by casting, molding, or machining.
- cutting head 250 may be manufactured separately from inner tubular 230 and then fixed to the distal end of inner tubular 230 by any suitable means, such as welding.
- Cutting head 250 preferably comprises a body 252 and three cutting arms 253 extending axially from body 252 .
- body 252 is integral with and essentially an extension of inner tubular 230 . Since each arm 253 extends axially from body 252 , each arm 253 may be described as including a fixed end 253 a integral with body 252 and a free end 253 b generally distal to body 252 .
- cutting head 250 may include any suitable number of cutting arms 253 including without limitation two, three, four, or more.
- Arms 253 are preferably integral with body 252 and inner tubular 230 .
- arms 253 may be formed by any suitable means including without limitation casting or molding, laser cutting, machining, or combinations thereof.
- arms 253 may alternatively be distinct components that are mechanically coupled to body 252 and inner tubular 230 generally at fixed end 253 a .
- arms 253 may be connected to inner tubular 230 by any suitable means, including without limitation welding, pins, or combinations thereof.
- bore 240 is contiguous with a tissue-receiving space 263 defined between arms 253 inside cutting head 250 .
- Tissue-receiving space 253 and bore 240 accommodate tissue excised by device 200 (e.g., excised pieces of ligamentum flavum).
- tissue-receiving space 263 inside cutting head 250 may include ridges, knurling or other textured surface features 264 thereon so as to further improve grasping and retention of tissue between arms 253 .
- Textured surface feature 264 may be formed by any suitable means including without limitation knurling, sand blasting, bead blasting, plasma etching, or combinations thereof.
- the inner surface of inner tubular 230 may be roughened to enhance the ability of inner bore 240 to enhance grasping and retention of excised portions of tissue.
- each arm 253 preferably terminates in a cutting or tissue-grasping member.
- two aims terminate in cutters 251 and a third arm terminates in a sharp anchoring tip 154 that extends beyond the distal ends of cutters 251 .
- Each cutting edge 251 preferably has a sharpened or beveled edge adapted to slice through tissue.
- anchoring tip 254 includes a tissue grasping member 257 that extends radially inward and helps grasp tissue and retain tissue within tissue-receiving space 263 .
- tissue grasping member 257 is a tooth.
- one or more tissue grasping members may comprise teeth, barbs, or the like. Tooth 257 preferably has sharpened edges to enhance cutting of tissue.
- arms 253 may be any desired length.
- Cutting head 250 is constructed so that arms 253 can be brought together so as to grasp tissue therebetween, termed herein as a “closed position”, and moved apart so as to release tissue and/or allow the entry of tissue between arms 253 , termed herein as an “open position”. As shown in FIGS. 31 and 32 , cutting head 250 is in an open position. Specifically when cutting head 250 is in an open position, cutting head 250 is extended from sleeve 210 and free ends 253 b of each arm 253 are radially spaced apart. Consequently, any tissue within tissue-receiving space 263 is not pinched or firmly grasped by arms 253 and tissue is allowed to enter tissue-receiving space 263 via the gap between free ends 253 b of arms 253 .
- each arm 253 preferably includes a frustoconical chamfer 255 on its outer surface.
- the surface of each frustoconical chamfer 255 extends radially beyond inner radius R 1 of sleeve 210 .
- cutting head 250 is extended from sleeve 210 and thus sleeve 210 does not engage frustoconical chamfer 255 .
- each frustoconical chamfer 255 is generally flee to extend radially beyond inner radius R 1 of sleeve 210 (i.e., sleeve 210 does engage chamfers 255 nor restrict arms 253 ).
- sleeve 210 when sleeve 210 is advanced toward cutting ends 253 b it engages the portions of frustoconical chamfer 255 that radially extend beyond inner radius R 1 of sleeve 210 , thereby tending to force arms 253 together.
- sleeve 210 continues to bear on chamfers 255 and arms 253 are brought closer together.
- Cutting head 250 achieves the closed position when arms 253 contact each other and/or when each radially outermost portions or ridge 260 of each frustoconical chamfer 255 is disposed within inner tubular 230 . At this point, cutting ends 253 b of each arm 253 are at their closest relative to each other. In some embodiments, cutting ends 253 b may engage adjacent cutting ends 253 b.
- sleeve 210 may be moved axially relative to cutting head 250 by any suitable manner including without limitation a threaded engagement with inner tubular 230 , a trigger mechanism, or combinations thereof.
- aims 253 are normally open.
- arms 253 are biased to the open position such that cutting head 250 will assume the open position when no forces are acting to push arms 153 together.
- compressive forces namely sleeve 210 acting on each frustoconical chamfer 255 .
- cutting head 253 will automatically assume the open position illustrated in FIG. 31 as sleeve 210 is retracted and cutting head 253 extends flom sleeve 210 .
- arms 253 may be biased closed and transitioned to an open position by providing an inner wedge between each arm 253 that urges the arms apart as it moves axially relative to arms 253 .
- FIGS. 34 and 35 schematically illustrate the excision of a portion of tissue 126 by device 200 .
- a portal or cannula (not shown) may be employed to provide percutaneous access to tissue 126 .
- tissue excision device 200 may be inserted into and advanced through such a portal or cannula to reach tissue 126 .
- tissue excision device 200 Regardless of the manner in which tissue excision device 200 reaches the tissue of interest (e.g., by portal or otherwise), prior to insertion into the tissue to be excised, device 200 is configured in the open position as shown in FIGS. 31 and 32 . With device 200 in the opened position, the distal portion of tissue excision device 200 is advanced into tissue 126 , as best shown in FIG. 34 .
- Tissue 126 may be any type of tissue to be excised and removed from a patient including without limitation, soft tissue, fat, muscle, or bone.
- cutting head 250 of device 200 is preferably inserted into the stenotic ligamentum flavum 26 , preferably posterior to a safety zone 40 , in order to safely cut and remove portions of the thickened ligamentum flavum 26 (see FIGS. 2 and 3 ), thereby reducing the stenosis.
- tissue 126 slide into and fill at least a portion of tissue-receiving space 263 between arms 253 within cutting head 250 . It is to be understood that the farther device 200 is advanced into tissue 126 , the greater the amount of tissue 126 that will occupy tissue-receiving space 263 . As tissue-receiving space 263 fills, some excess tissue within tissue-receiving space 263 may be pushed into bore 240 of inner tubular 230 . Arms 253 are preferably rigid such that cutting head 250 does not inadvertently transition to the closed position as device 200 is advanced through the tissue. In other words, arms 253 are preferably rigid so that the forces exerted on the outer surface of arms 253 by the surrounding tissue 126 as device 200 is advanced do not tend to move arms 253 towards each other.
- device 200 may be transitioned to the closed position by advancing sleeve 210 toward cutting ends 253 b and over cutting head 250 as previously described.
- the portions of tissue 126 within tissue-receiving space 263 and bore 240 are severed from the surrounding tissue 126 .
- the sharpened or beveled edges of cutters 251 and tooth 257 slice tissue extending axially from tissue-receiving space 263
- an annular cutting edge 211 of sleeve 210 slices tissue extending radially from tissue-receiving space 263 between arms 253 .
- Cutting edge 211 of sleeve 210 is preferably sharpened to enhance the cutting ability of sleeve 210 as it moves relative to cutting head 250 .
- the severed tissue 126 contained within tissue-receiving space 263 is grasped by arms 253 .
- arms 253 exert compressive forces on the tissue 126 within tissue-receiving space 263
- the textured surface features 264 on the inner surface of arms 253 grips the tissue 126 within tissue-receiving space 263
- tooth 257 grasps tissue 126 within tissue-receiving space 263 and restricts it from sliding axially out of cutting head 250 between cutting ends 253 b.
- device 200 maybe retracted from tissue 126 as best shown in FIG. 35 .
- the portion of tissue 126 contained within tissue-receiving space 263 and bore 240 is removed along with device 200 .
- device 200 including a portion of tissue 126 within tissue-receiving space 263 and bore 240 , has been completely removed from the patient, resected tissue within tissue-receiving space 263 and bore 240 is removed from device 200 so that device 200 may be reinserted into tissue 126 to continue to the cutting and removal of portions of tissue 126 .
- Pieces of tissue 126 captured within tissue-receiving space 263 and bore 240 may be removed by simply opening device 200 and pulling the pieces of tissue from tissue-receiving space 263 and bore 240 .
- Device 200 may be opened from the closed position by retracting sleeve 210 from cutting head 250 as previously described. As device 200 transitions to its opened position, arms 253 will separate, allowing the user to access tissue-receiving space 263 and inner bore 240 .
- a plunger or tissue ejector may be included with device 200 to physically eject the excised tissue 126 from tissue-receiving space 263 and inner bore 240 .
- a plunger (not shown) may be included within device 200 to push cut tissue in tissue-receiving space 263 and inner bore 240 axially out through the opening between cutting ends 253 b of arms 253 .
- the process of inserting device 200 into tissue 126 in the opened position, closing device 126 , retracting device 200 in the closed position, opening device 200 , emptying tissue-receiving space 263 and bore 240 , and reinserting device 200 may be repeated until the desired amount of tissue 126 has been excised and removed.
- this process may be repeated until the spinal canal is adequately decompressed.
- the cutting ends 253 b of each arm 253 of device 200 are preferably controlled to remain within ligamentum flavum 26 and not penetrate safety zone 40 . Nonetheless, safety zone 40 is preferably provided so that even an inadvertent penetration into epidural space 27 by device 200 will not result in damage to the dural sac 32 or nerves 34 .
- tissue excision device 200 may comprise any suitable material(s) including without limitation metals (e.g., stainless steel, titanium, etch), non-metals (e.g., polymer, composites, etc.) or combinations thereof.
- the components of tissue excision device 200 are preferably manufactured from a durable biocompatible material such as titanium or stainless steel, but may alternatively be polymeric.
- arms 253 each preferably comprise a relatively rigid material(s) capable of maintaining their shape and configuration when inserted into and advanced through tissue.
- arms 253 preferably comprises a resilient material having the ability to be repeatedly flexed between the open position and closed position without cracking or otherwise being damaged. Such a resilient material also enables each arm 253 to return to its original configuration once external forces (e.g., force applied by sleeve 210 ) are removed.
- tissue excision device 200 may be manufactured by any suitable methods. Examples of suitable methods include casting or molding, machining, laser cutting, EMD, or combinations thereof. In some embodiments, cutting edges or tips may be electro polished to for sharpening.
- the components of tissue excision device 200 may be assembled by any suitable method including without limitation welding, press fitting, or combinations thereof.
Abstract
Description
- This application claims benefit of U.S. provisional application Ser. No. 60/704,224 filed Jul. 29, 2005, and entitled “Device for Resecting Spinal Tissue,” which is hereby incorporated herein by reference in its entirety. This application also claims benefit of U.S. provisional application Ser. No. 60/747,166 filed May 12, 2006, and entitled “Percutaneous Tissue Excision Devices and Methods,” which is hereby incorporated herein by reference in its entirety.
- Not Applicable.
- The present invention relates generally to minimally invasive methods, devices and systems for treating spinal disorders using imaging guidance. More particularly, the present invention relates to devices and methods to reduce stenosis and increase the cross-sectional area of the spinal canal available for the spinal cord. Still more particularly, the present invention relates to devices and methods to percutaneously excise portions of an enlarged ligamentum flavum.
- The present invention relates generally to a minimally invasive method, device and system for treating spinal disorders using imaging guidance. More particularly, this invention relates to devices and tools that provide a percutaneous portal to tissues in a region of interest. Still more particularly, this invention relates to devices and tools that provide percutaneous portals to tissue through bone.
- The vertebral column (spine, spinal column, backbone) forms the main part of the axial skeleton, provides a strong yet flexible support for the head and body, and protects the spinal cord disposed in the vertebral canal, which is formed within the vertebral column. The vertebral column comprises a stack of vertebrae with an intervertebral disc between adjacent vertebrae. The vertebrae are stabilized by muscles and ligaments that hold the vertebrae in place and limit the movements of the vertebrae.
- As illustrated in
FIG. 1 , eachvertebra 10 includes avertebral body 12 that supports avertebral arch 14. Amedian plane 210 generally dividesvertebra 10 into two substantially equal lateral sides.Vertical body 12 has the general shape of a short cylinder and is anterior to thevertebral arch 14. Thevertebral arch 14 together withvertebral body 12 encloses a space termed thevertebral foramen 15. The succession ofvertebral foramen 15 inadjacent vertebrae 10 along the vertebral column define the vertebral canal (spinal canal), which contains the spinal cord. -
Vertebral arch 14 is formed by twopedicles 24 which project posteriorly to meet twolaminae 16. The twolaminae 16 meet posteriomedially to form thespinous process 18. At the junction ofpedicles 24 andlaminae 16, six processes arise. Twotransverse processes 20 project posterolaterally, two superiorarticular processes 22 project generally superiorly and are positioned superior to two inferiorarticular processes 25 that generally project inferiorly. - The
vertebral foramen 15 is generally an oval shaped space that contains and protects thespinal cord 28.Spinal cord 28 comprises a plurality ofnerves 34 surrounded by cerebrospinal fluid (CSF) and an outermost sheath/membrane called thedural sac 32. The CSF filleddural sac 32 containingnerves 34 is relatively compressible. Posterior to thespinal cord 28 withinvertebral foramen 15 is theligamentum flavum 26.Laminae 16 of adjacentvertebral arches 14 in the vertebral column are joined by the relatively broad,elastic ligamentum flavum 26. - In degenerative conditions of the spine, narrowing of the spinal canal (stenosis) can occur. Lumbar spinal stenosis is often defined as a dural sac cross-sectional area less than 100 mm2 or an anteroposterior (AP) dimension of the canal of less than 10-12 mm for an average male.
- The source of many cases of lumbar spinal stenosis is thickening of the ligamentum flavum. Spinal stenosis may also be caused by subluxation, facet joint hypertrophy, osteophyte formation, underdevelopment of spinal canal, spondylosis deformans, degenerative intervertebral discs, degenerative spondylolisthesis, degenerative arthritis, ossification of the vertebral accessory ligaments and the like. A less common cause of spinal stenosis, which usually affects patients with morbid obesity or patients on oral corticosteroids, is excess fat in the epidural space. The excessive epidural fat compresses the dural sac, nerve roots and blood vessels contained therein and resulting in back and leg pain and weakness and numbness of the legs. Spinal stenosis may also affect the cervical and, less commonly, the thoracic spine.
- Patients suffering from spinal stenosis are typically first treated with exercise therapy, analgesics and anti-inflammatory medications. These conservative treatment options frequently fail. If symptoms are severe, surgery is required to decompress the canal and nerve roots.
- In some conventional approaches to correct stenosis in the lumbar region, an incision is made in the back and the muscles and supporting structures are stripped away from the spine, exposing the posterior aspect of the vertebral column. The thickened ligamentum flavum is then exposed by removal of a portion of the vertebral arch, often at the laminae, covering the back of the spinal canal (laminectomy). The thickened ligamentum flavum ligament can then be excised by sharp dissection with a scalpel or punching instruments such as a Kerison punch that is used to remove small chips of tissue. The procedure is performed under general anesthesia. Patients are usually admitted to the hospital for approximately five to seven days depending on the age and overall condition of the patient. Patients usually require between six weeks and three months to recover from the procedure. Further, many patients need extended therapy at a rehabilitation facility to regain enough mobility to live independently.
- Much of the pain and disability after an open laminectomy results from the tearing and cutting of the back muscles, blood vessels, supporting ligaments, and nerves that occurs during the exposure of the spinal column. Also, because the spine stabilizing back muscles and ligaments are stripped and detached from the spine during the laminectomy, these patients frequently develop spinal instability post-operatively.
- Minimally invasive techniques offer the potential for less post-operative pain and faster recovery compared to traditional open surgery. Percutaneous interventional spinal procedures can be performed with local anesthesia, thereby sparing the patient the risks and recovery time required with general anesthesia. In addition, there is less damage to the paraspinal muscles and ligaments with minimally invasive techniques, thereby reducing pain and preserving these important stabilizing structures.
- Various techniques for minimally invasive treatment of the spine are known. Microdiscectomy is performed by making a small incision in the skin and deep tissues to create a portal to the spine. A microscope is then used to aid in the dissection of the adjacent structures prior to discectomy. The recovery for this procedure is much shorter than traditional open discectomies. Percutaneous discectomy devices with fluoroscopic guidance have been used successfully to treat disorders of the disc but not to treat spinal stenosis or the ligamentum flavum directly. Arthroscopy or direct visualization of the spinal structures using a catheter or optical system have also been proposed to treat disorders of the spine including spinal stenosis, however these devices still use miniaturized standard surgical instruments and direct visualization of the spine similar to open surgical procedures. These devices and techniques are limited by the small size of the canal and these operations are difficult to perform and master. In addition, these procedures are painful and often require general anesthesia. Further, the arthroscopy procedures are time consuming and the fiber optic systems are expensive to purchase and maintain.
- Still further, because the nerves of the spinal cord pass through the spinal canal directly adjacent to and anterior to the ligamentum flavum, any surgery, regardless of whether open or percutaneous, includes a risk of damage to the nerves of the spinal cord.
- Hence, it remains desirable to provide simple methods, techniques, and devices for treating spinal stenosis and other spinal disorders without requiring open surgery. It is further desired to provide a system whereby the risk of damage to the dural sac containing the spinal nerves may be reduced.
- These and other needs in the art are addressed in one embodiment by a device for excising tissue. In an embodiment, the device comprises an outer sleeve. In addition, the device comprises an inner tubular member slidingly received within the outer sleeve. Further the device comprises a cutting head connected to a distal end of the inner tubular, wherein the cutting head comprises at least three arms extending axially from the inner tubular. Still further, the device has an open position in which the cutting head extends from the outer sleeve, and a closed position in which the cutting head is at least partially disposed within the sleeve.
- These and other needs in the art aye addressed in another embodiment by a method for treating stenosis in a spine of a patient having a median plane, the spine including a spinal canal having a posterior surface, a dural sac and an epidural space between the posterior surface and dural sac, the location of the stenosis determining a region of interest in the spine. In an embodiment, the method comprises the step of positioning a tissue excision device adjacent the region of interest, wherein the tissue excision device comprises an outer sleeve, an inner tubular member slidingly received within the outer sleeve, and a cutting head connected to a distal end of the inner tubular, the cutting head including at least three arms extending axially from the inner tubular. In addition, the method comprises the step of opening the tissue excision device by extending the cutting head from the outer sleeve. Further, the method comprises the step of inserting the tissue excision device into tissue in the region of interest. Still further, the method comprises the step of closing the tissue excision device by advancing the outer sleeve over the cutting head. Moreover, the method comprises the step of retracting the tissue excision device from the tissue in the region of interest.
- These and other needs in the art are addressed in another embodiment by a kit for performing a procedure on a spine, the spine including an epidural space containing a dural sac. In an embodiment, the kit comprises an insertion member for accessing the epidural space. In addition, the kit comprises a volume of a contrast medium adapted to be inserted into the epidural space by the insertion member and expanded so as to compress a portion of the thecal sac and provide a safety zone within the epidural space. Further, the kit comprises a tissue excision device comprising an outer sleeve, an inner tubular member slidingly received within the outer sleeve, a cutting head connected to a distal end of the inner tubular, wherein the cutting head comprises at least three arms extending axially from the inner tubular.
- Thus, embodiments described herein comprise a combination of features and advantages intended to address various shortcomings associated with certain prior devices. The various characteristics described above, as well as other features, will be readily apparent to those skilled in the art upon reading the following detailed description of the preferred embodiments, and by referring to the accompanying drawings. It should be appreciated by those skilled in the art that the conception and the specific embodiments disclosed may be readily utilized as a basis for modifying or designing other structures for carrying out the same purposes of the embodiments described herein. It should also be realized by those skilled in the art that such equivalent constructions do not depart from the spirit and scope of the invention as set forth in the appended claims.
- For a more complete understanding of the invention, reference is made to the accompanying drawings, wherein:
-
FIG. 1 is cross-section of the spine viewed from the space between two vertebrae, showing the upper surface of one vertebra and the spinal canal with the dural sac and a normal (un-stenosed) ligamentum flavum therein; -
FIG. 2 is an illustration of the same section asFIG. 1 , showing the spinal canal with the dural sac and a thickened ligamentum flavum therein; -
FIG. 3 is an enlarged cross-section of a vertebral foramen, showing a safety zone created by compression of the dural sac; -
FIG. 4 is the cross-section ofFIG. 3 , showing a tissue excision tool positioned in the ligamentum flavum; -
FIGS. 5-9 are a series of illustrations showing tissue excision by a tissue-excision tool constructed in accordance with a first embodiment of the invention; -
FIGS. 10-14 are a series of illustrations showing tissue excision by a tissue-excision tool constructed in accordance with a second embodiment of the invention; -
FIGS. 15 and 17 are sequential illustrations showing removal of tissue from a tissue-excision tool by a tissue-removal device constructed in accordance with an embodiment of the invention; -
FIGS. 16 and 18 are end views of the tissue-removal device ofFIGS. 15 and 17 , respectively; -
FIG. 19 shows an alternative embodiment of a grasping needle with a corkscrew shape; -
FIG. 20 is a perspective view of a tissue-excision tool constructed in accordance with a third embodiment of the invention; -
FIGS. 21 and 22 are enlarged cross-sectional and perspective views, respectively, of the grasping device ofFIG. 20 in its retracted position; -
FIGS. 23 and 24 are enlarged cross-sectional and perspective views, respectively, of the grasping device ofFIG. 20 in its extended position; -
FIG. 25 is a schematic illustration of one embodiment of a double-ended ligament anchor being deployed in a ligamentum flavum; -
FIG. 26 shows the device ofFIG. 25 after full deployment; -
FIG. 27 is a perspective view of an entire tool constructed in accordance with preferred embodiments; -
FIG. 28 is an enlarged cross-sectional view of the distal tip of the tool ofFIG. 27 with the aperture partially opened; -
FIG. 29 is a cross-sectional view of the handle end of the tool ofFIG. 27 ; -
FIG. 30 is cross-section of another embodiment of a tissue-removal device; -
FIG. 31 is a perspective view of the distal portion of an embodiment of a tissue excision device in an open position; -
FIG. 32 is an end-view of the tissue excision device ofFIG. 31 ; -
FIG. 33 is a perspective view of the tissue excision device ofFIG. 31 transitioning from the open position to the closed position; and -
FIGS. 34 and 35 are sequential schematic illustrations showing the excision of tissue by the tissue excision tool illustrated inFIG. 31 . - The following discussion is directed to various embodiments of the invention. Although one or more of these embodiments may be preferred, the embodiments disclosed should not be interpreted, or otherwise used, as limiting the scope of the disclosure, including the claims. In addition, one skilled in the art will understand that the following description has broad application, and the discussion of any embodiment is meant only to be exemplary of that embodiment, and not intended to intimate that the scope of the disclosure, including the claims, is limited to that embodiment
- For purposes of this discussion, the x-, y-, and z-axes are shown in
FIGS. 1 and 3 to aid in understanding the descriptions that follow. The x-, y-, and z-axes have been assigned as follows. The x-axis is perpendicular to the longitudinal axis of the vertebral column and perpendicular to the coronal/frontal plane (i.e., x-axis defines anterior vs. posterior relationships). The y-axis runs substantially parallel to the vertebral column and perpendicular to the transverse plane (i.e., y-axis defines superior vs. inferior relationships). The z-axis is perpendicular to the longitudinal axis of the vertebral column and perpendicular to the median/midsagittal plane (i.e., z-axis defines the lateral right and left sides of body parts). The set of coordinate axes (x-, y-, and z-axes) are consistently maintained throughout although different views of vertebrae and the spinal column may be presented. - It is to be understood that the median/midsagittal plane passes from the top to the bottom of the body and separates the left and the right sides of the body, and the spine, into substantially equal halves (e.g., two substantially equal lateral sides). Further, it is to be understood that the frontal/coronal plane essentially separates the body into the forward (anterior) half and the back (posterior) half, and is perpendicular to the median plane. Still further, it is to be understood that the transverse plane is perpendicular to both the median plane and coronal plane and is the plane which divides the body into an upper and a lower half.
- The Spinal Canal and Spinal Stenosis
- Referring again to
FIG. 1 ,vertebral foramen 15 contains a portion of the ligamentum flavum 26,spinal cord 28, and anepidural space 27 between ligamentum flavum 26 andspinal cord 28.Spinal cord 28 comprises a plurality ofnerves 34 surrounded by cerebrospinal fluid (CSF) contained withindural sac 32.Nerves 34 normally comprise only a small proportion of thedural sac 32 volume. Thus, CSF filleddural sac 32 is somewhat locally compressible, as localized pressure causes the CSF to flow to adjacent portions of the dural sac.Epidural space 27 is typically filled with blood vessels and fat. The posterior border of the normalepidural space 27 generally defined by theligamentum flavum 26, which is shown in its normal, non-thickened state inFIG. 1 . -
FIG. 2 illustrates a case of spinal stenosis resulting from a thickenedligamentum flavum 26. Sincevertebral foramen 15 is defined and surrounded by the relatively rigid bone its volume is substantially constant. Thus, thickening of ligamentum flavum 26 withinvertebral foramen 15 can eventually result in compression ofspinal cord 28. In particular, the thickenedligamentum flavum 26 may exert a compressive force on the posterior surface ofdural sleeve 32. In addition, thickening of ligamentum flavum 26 may compress the blood vessels and fat occupyingepidural space 27. - Compression of
spinal cord 28, particularly in the lumbar region, may result in low back pain as well as pain or abnormal sensations in the legs. Further, compression of the blood vessels in theepidural space 27 that houses the nerves of the cauda equina may result in ischemic pain termed spinal claudication. - In order to relieve the symptoms associated with a thickened or enlarged ligamentum flavum 26, methods, techniques, and devices described herein may be employed to reduce the compressive forces exerted by the thickened ligamentum flavum on
spinal cord 28 and the blood vessels in epidural space 27 (ergo, decompressspinal cord 28 and blood vessels in epidural space 27). In particular, compressive forces exerted by the thickened/enlarged ligamentum flavum 26 may be reduced by embodiments of a minimally invasive ligament decompression (MILD) procedure described herein. In some embodiments, the MILD procedure may be performed percutaneously to reduce the size of ligamentum flavum 26 by excising portions of ligamentum flavum 26. In particular, in some embodiments of the MILD procedure, the ligamentum flavum 26 is accessed, cut and removed ipsilaterally (i.e., on the same side of vertebral arch 14) by a percutaneous cranial-caudal approach. Such an embodiment of the MILD procedure may be described hereinafter as Ipsilateral Approach MILD Procedure (ILAMP). - Creation of Safety Zone
- As shown in
FIGS. 1 and 2 ,ligamentum flavum 26 is posteriorly apposed tospinal cord 28. Thus, placement of tools within ligamentum flavum 26 to excise portions of ligamentum flavum 26 creates a risk of for inadvertent damage to thespinal cord 28,dural sac 32, and/ornerves 34. Thus, in preferred embodiments of the procedures described herein, prior to insertion of tissue removal tools into theligamentum flavum 26, a gap is advantageously created between ligamentum flavum 26 and spinal cold 28 to provide a safety zone between ligamentum flavum 26 andspinal cord 28. -
FIG. 3 illustrates an enlarged cross-sectional view of avertebral foramen 15 within a vertebra.Vertebral foramen 15 includesepidural space 27 andspinal cord 28 containingnerves 34 and CSF withindural sac 32. Further, a thickened/enlarged ligamentum flavum 26 extends intovertebral foramen 15. To reduce the risk of damage todural sac 32 andspinal cord 28, asafety zone 40 is created between ligamentum flavum 26 anddural sac 32. - As previously described,
spinal cord 28 comprisesnerves 34 surrounded by CSF and is contained withindural sac 32. Since more than 90% of the volume ofdural sac 32 in the lumbar region is filled by CSF,dural sac 32 is highly compressible. Thus, even when stenosis is causing compression ofspinal cord 28, in most cases it is possible to temporarily compressspinal cord 28 further. Thus, according to preferred embodiments,dural sac 32 is further compressed in the region of interest by injecting a fluid intoepidural space 27 to createsafety zone 40. The presence of the injected fluid comprisingsafety zone 40 gently applies an additional compressive force to the outer surface ofdural sac 32 so that at least a portion of the CSF withindural sac 32 is forced out ofdural sac 32 in the region of interest, resulting insafety zone 40 betweendural sac 32 andligamentum flavum 26. - According to some embodiments,
dural sac 32 is compressed by injecting a standard radio-opaque non-ionic myelographic contrast medium or other imagable or non-imagable medium intoepidural space 27 in the region of interest. This is preferably accomplished with a percutaneous injection. Sufficient injectable fluid is preferably injected to displace the CSF out of the region of interest and compressdural sac 32 to at least a desired degree. The injected medium is preferably substantially contained within the confines ofepidural space 27 extending to the margins of thedural sac 32. The epidural space is substantially watertight and the fatty tissues and vascularization inepidural space 27, combined with the viscous properties of the preferred fluids, serve to substantially maintain the injected medium in the desired region of interest. This novel method for protectingspinal cord 28 column may be referred to hereinafter as “contrast-guided dural protection.” - Once a
safety zone 40 has been created, atool 100, such as the tissue excision devices and tissue retraction devices described below, may be inserted into theligamentum flavum 26, as illustrated inFIG. 4 .Tool 100 may comprise any suitable device, tool, or instrument for relieving stenosis caused by the thickened/enlarged ligamentum flavum 26 including without limitation, embodiments of tissue excision devices and tissue retraction devices described in more detail below. Further, as best illustrated inFIG. 4 ,tool 100 is positioned in theligamentum flavum 26 on the opposite side ofmedian plane 210 astool 100 percutaneously accesses the body, such thattool 100 crossesmedian plane 210. In another embodiment,tool 100 is inserted and positioned in theligamentum flavum 26 on the same side (ipsilateral) ofmedian plane 210 astool 100 percutaneously accesses the body, such thattool 100 does not crossmedian plane 210. - While it is preferred that the tip of
tool 100 remain within ligamentum flavum 26 as shown, the presence ofsafety zone 40 reduces the likelihood thatdural sac 32 will be damaged, even if the tool breaks through the anterior surface of ligamentum flavum 26. - For insertion of
tool 100, a fluoroscopic window of access (FWA) is defined by the inferior margin of the lamina (contra lateral to the point of instrument entry in the soft tissues) and the dorsal margin of the contrast material that defines the epidural space. This FWA is roughly orthogonal to the long axis of the cutting instrument, which parallels the inferior surface of the lamina as inFIG. 4 . The fluoroscopic plane of projection is preferably but not necessarily oriented 20-40 degrees from normal (AP projection). - Because the present techniques are preferably performed percutaneously, certain aspects of the present invention may be facilitated by imaging. In this context, the spine can be imaged using any suitable technology, including without limitation, 2D fluoroscopy, 3D fluoroscopy, CT, MRI, ultrasound or with direct visualization with fiber optic or microsurgical techniques. Stereotactic or computerized image fusion techniques are also suitable. Fluoroscopy is currently particularly well-suited to the techniques disclosed herein. Fluoroscopic equipment is safe and easy to use, readily available in most medical facilities, relatively inexpensive. In a typical procedure, using direct biplane fluoroscopic guidance and local anesthesia,
epidural space 27 is accessed for injection of contrast media adjacent to the surgical site. - If the injected medium is radio-opaque, as are for example myelographic contrast media, the margins of the expanded epidural space will be readily visible using fluoroscopy or CT imaging. Thus, the safety zone created by the present contrast-guided dural compression techniques can reduce the risk of damage to the spinal cord during procedures to remove or displace portions of the ligamentum flavum and/or laminae in order to treat spinal stenosis.
- Injectable Medium
- If desired, the injected medium can be provided as a re-absorbable water-soluble gel, so as to better localize
safety zone 40 at the site of surgery and reduce leakage of this protective layer from the vertebral/spinal canal. An injectable gel is a significant improvement on prior epidural injection techniques. The gel is preferably substantially more viscid than conventional contrast media and the relatively viscid and/or viscous gel preferably tends to remain localized at the desired site of treatment as it does not spread as much as standard liquid contrast media that are used in epidurography. This may result in more uniform compression ofdural sac 32 and less leakage of contrast out of the vertebral/spinal canal. In addition, preferred embodiments of the gel are re-absorbed more slowly than conventional contrast media, allowing for better visualization during the course of the surgical procedure. - In some embodiments, a contrast agent can be included in the gel itself, so that the entire gel mass is imagable. In other embodiments, an amount of contrast can be injected first, followed by the desired amount of gel, or an amount of gel can be injected first, followed by the desired amount of contrast. In this case, the contrast agent is captured on the surface of the expanding gel mass, so that the periphery of the mass is imagable.
- Any standard hydrophilic-lipophilic block copolymer (Pluronic) gel such as are known in the art would be suitable and other gels may be used as the injectable medium. The gel preferably has an inert base. In certain embodiments, the gel material is liquid at ambient temperatures and can be injected through a small bore (such as a 27 gauge needle). The gel then preferably becomes viscous when warmed to body temperature after being injected. The viscosity of the gel can be adjusted through the specifics of the preparation. The gel or other fluid is preferably sufficiently viscid or viscous at body temperature to compress and protect the thecal sac in the manner described above and to remain sufficiently present in the region of interest for at least about 30 minutes. Thus, in some embodiments, the injected gel attains a viscosity that is two, three, six or even ten times that of the fluids that are typically used for epidurograms.
- In certain embodiments, the injected medium undergoes a reversible change in viscosity when warmed to body temperature so that it can be injected as a low-viscosity fluid, thicken upon injection into the patient, and be returned to its low-viscosity state by cooling. In these embodiments, the injected medium is injected as desired and thickens upon warming, but can be removed by contacting it with a heat removal device, such as an aspirator that has been provided with a cooled tip. As a result of localized cooling, the gel reverts to its initial non viscous liquid state and can be easily suctioned up the cooled needle or catheter.
- An example of a suitable contrast medium having the desired properties is
Omnipaque® 240 available from Nycomed, New York, which is a commercially available non-ionic iodinated myelographic contrast medium. Other suitable injectable media will be known to those skilled in the art. Because of the proximity tospinal cord 28 andspinal nerves 34, it is preferred not to use ionic media in the injectable medium. The preferred compositions are reabsorbed relatively rapidly after the procedure. Thus any residual gel compression ondural sac 32 after the MILD procedure dissipates relatively quickly. For example, in preferred embodiments, the gel would have sufficient viscosity to compressdural sac 32 for thirty minutes, and sufficient degradability to be substantially reabsorbed within approximately two hours. - The injected contrast medium further may further include one or more bioactive agents. For example, medications such as those used in epidural steroid injection (e.g. Depo medrol, Celestone Soluspan) may be added to the epidural gel to speed healing and reduce inflammation, scarring and adhesions. The gel preferably releases the steroid medication slowly and prolongs the anti-inflammatory effect, which can be extremely advantageous. Local anesthetic agents may also be added to the gel. This prolongs the duration of action of local anesthetic agents in the epidural space to prolong pain relief during epidural anesthesia. In this embodiment the gel may be formulated to slow the reabsorption of the gel.
- The present gels may also be used for epidural steroid injection and perineural blocks for management of acute and chronic spinal pain. Thrombin or other haemostatic agents can be added if desired, so as to reduce the risk of bleeding.
- In some embodiments, the gel may also be used as a substitute for a blood patch if a CSF leak occurs. The gel may also be used as an alternative method to treat lumbar puncture complications such as post-lumbar puncture CSF leak or other causes of intracranial hypotension. Similarly, the gel may be used to patch postoperative CSF leaks or dural tears. If the dural sac were inadvertently torn or cut, then gel could immediately serve to seal the site and prevent leakage of the cerebral spinal fluid.
- Percutaneous Tissue Excision
- After
safety zone 40 has been created, the margins ofepidural space 27 are clearly demarcated by the injected medium and can be visualized radiographically if an imagable medium has been used. As mentioned above, percutaneous procedures can now safely be performed onligamentum flavum 26 and/or surrounding tissues without injuringdural sac 32 ornerves 34 and the spinal canal can be decompressed using any of several techniques. Suitable decompression techniques include removal of tissue from the ligamentum flavum, laminectomy, laminotomy, and ligament retraction and anchoring. - In some embodiments, all or a portion of ligamentum flavum 26 and/or
lamina 16 are excised using a percutaneous tissue excision device or probe 100, which may hereinafter be referred to as the MILD device. As shown schematically inFIG. 4 , adevice 100 may be placed parallel to the posterior and lateral margin of thesafety zone 40 with its tip in theligamentum flavum 26. - Preferred embodiments of the present tissue excision devices and techniques can take several forms. In the discussion below, the distal ends of the tools are described in detail. The construction of the proximal ends of the tools, and the means by which the various components disclosed herein are assembled and actuated, will be known and understood by those skilled in the art.
- By way of example, in the embodiment shown in
FIG. 4 and as illustrated inFIG. 5 ,device 100 maybe a coaxial excision system 50 with a sharpened or blunt tip that is placed obliquely into the thickenedligamentum flavum 26 posterior tosafety zone 40 under fluoroscopic guidance. The needle is preferably placed parallel to the posterior margin of the canal. Excision system 50 is preferably manufactured from stainless steel, titanium or other suitable durable biocompatible material. As shown inFIGS. 5-10 , an outer needle orcannula 51 has an opening oraperture 52 on one side that is closed during insertion by aninner occluding member 54.Aperture 52 is readily visible under imaging guidance. Onceneedle 51 is positioned in the ligamentum flavum or other tissue removal site, inner occludingmember 54 is removed or retracted so that it no longer closes aperture 52 (FIG. 6 ).Aperture 52 is preferably oriented away from the epidural space so as to further protect the underlying structures from injury during the surgical procedure. If it was not already present in the tool, a tissue-engagingmeans 56 is inserted throughouter needle 51 toaperture 52 so that it contacts adjacent tissue, e.g., the ligamentum flavum, viaaperture 52. - Tissue-engaging
means 56 may be a needle, hook, blade, tooth or the like, and preferably has at least one flexible barb orhook 58 attached to its shaft. Thebarb 58 or barbs may extend around approximately 120 degrees of the circumference of the shaft.Barbs 58 are preferably directed towards the proximal end of the tool. When tissue-engagingmeans 56 is retracted slightly,barbs 58 allow it to engage a segment of tissue. Depending on the configuration ofbarbs 58, the tissue sample engaged by tissue-engagingmeans 56 may be generally cylindrical or approximately hemispherical. Onceneedle 56 has engaged the desired tissue, inner occluding means 54, which is preferably provided with a sharpened distal edge, is advanced so that it cuts the engaged tissue section or sample loose from the surrounding tissue. Hence occluding means 54 also functions as a cutting means in this embodiment. In alternative embodiments, such asFIGS. 10-14 discussed below, a cylindrical outer cuttingelement 60 may extended overouter needle 51 and used in place of occludingmember 54 to excise the tissue sample. - Referring still to
FIGS. 5-9 , once the tissue sample has been cut, tissue-engagingneedle 56 can be pulled back throughouter needle 51 so that the segment of tissue can be retrieved and removed from the barbs (FIG. 8 ). The process or engaging and resecting tissue may be repeated (FIG. 9 ) until the canal is adequately decompressed. - Referring briefly to
FIGS. 10-14 , in other embodiments, a tissue-engaginghook 64 can be used in place ofneedle 56 and anouter cutting member 60 can be used in place of inner occludingmember 54.Hook 64 may comprise a length of wire that has been bent through at least about 270°, more preferably through 315°, and still more preferably through about 405°. Alternatively or in addition,hook 64 may comprise Nitinol™, or any other resilient metal that can withstand repeated elastic deflections. In the embodiment illustrated,hook 64 includes at least onebarb 58 at its distal end. In some embodiments,hook 64 is pre-configured in a curvilinear shape and is retained withintool 100 by outer cuttingmember 60. When cuttingmember 60 is retracted, the curved shape ofhook 64 urges its outer end to extend outward throughaperture 52. If desired, hook 64 can be advanced toward the distal end oftool 100, causing it to extend farther into the surrounding tissue. In some embodiments,hook 64 is provided with acamming surface 66.Camming surface 66 beats on the edge of opening 52 ashook 64 is advance or retracted and thereby facilitates retraction and retention ofhook 64 as it is retracted into the tool. In these embodiments,hook 64 may not extend throughaperture 52 until it has been advanced sufficiently forcamming surface 66 to clear the edge of the opening.Hook 64 may alternatively be used in conjunction with aninner occluding member 54 in the manner described above. As above, hook 64 can be used to retrieve the engaged tissue from the distal end of the tool. - In still other embodiments, the tissue-engaging means may comprise a hook or tooth or the like that engages tissue via
aperture 52 by being rotated about the tool axis. In such embodiments (not shown) and by way of example only, the tissue-engaging means could comprise a partial cylinder that is received inouter cannula 51 and has a serrated side edge. Such a device can be rotated via a connection with the tool handle or other proximal device. As the serrated edge traversesaperture 52 tissue protruding into the tool via the aperture is engaged by the edge, whereupon it can be resected and retrieved in the manner disclosed herein. - In preferred embodiments, the working tip of
tool 100 remains within the ligamentum flavum and does not penetrate thesafety zone 40. Nonetheless,safety zone 40 is provided so that even an inadvertent penetration of the tool into the epidural space will not result in damage to the thecal sac. Regardless of the means by which the tissue is engaged and cut, it is preferably retrieved from the distal end of the tool so that additional tissue segments can be excised without requiring that the working tip of the tool be repositioned. A tissue-removal device such as that described below is preferably used to remove the tissue from the retrieval device between each excision. - Tissue Removal
- Each piece of tissue may be removed from
barbs 58 by pushing tissue-engagingmeans 56 through an opening that is large enough to allow passage of the flexible barbs and supporting needle but smaller than the diameter of the excised tissue mass. This pushes the tissue up onto the shaft, where it can be removed with a slicing blade or the like or by sliding the tissue over the proximal end of the needle. Alternatively,needle 56 can be removed and re-inserted into the tool for external, manual tissue removal. - It is expected that in some embodiments, approximately 8-10 cores or segments of tissue will be excised and pushed up the shaft towards the hub during the course of the procedure. Alternatively, a small blade can be used to split the tissue segment and thereby ease removal of the segment from the device. If desired, a blade for this purpose can be placed on the shaft of
needle 56 proximal to the barbs. - In an exemplary embodiment, shown in
FIGS. 15-18 , the tissue removal device may include ascraper 120 that includes a keyhole slot having awide end 122 and a narrow end 124. To remove a tissue sample fromneedle 56 orhook 64, the tissue-engaging device with a mass of excisedtissue 110 thereon can be retracted (pulled toward the proximal end of the tool) throughwide end 122 of the slot and then re-inserted (pushed toward the distal end of the tool) through narrow end 124 of the slot. Narrow end 124 is large enough to allow passage of the barbed needle, but small enough to remove the tissue mass as the needle passes through. The removed tissue can exit the tool through anopening 113 in the tool body. By shuttling the tissue-engaging device throughscraper 120 in this manner, each excised segment oftissue 110 can be removed from the device, readying the device for another excision. - In an alternative embodiment shown in
FIG. 30 , the tissue removal device may be constructed such that tissue is removed from the tissue-engaging device by retracting the tissue-engaging device through narrow end 124 of the slot. As above, narrow end 124 is large enough to allow passage of the shaft of the tissue-engaging device, but small enough to remove the tissue mass as the needle passes through. If the tissue-engaging device is constructed of a tough material, the barbs or the like will cut through the tissue and/or deform and release the tissue. As above, the removed tissue can exit the tool through anopening 113 in the tool body. By shuttling the tissue-engaging device throughscraper 120 in this manner, each excised segment oftissue 110 can be removed from the device, readying the device for another excision. - In another alternative embodiment (not shown) an alternative mechanism for removing the tissue segment from
needle 56 includes an adjustable aperture in a disc. After the tissue-bearing needle is pulled back through the aperture, the aperture is partially closed.Needle 56 andflexible hooks 58 then can pass through the partially closed aperture but the larger cylinder of tissue cannot. Thus the tissue segment is pushed back onto the shaft. The tissue segment can either be pulled off the proximal end of the shaft or cut off of it. A small blade may be placed just proximal to the barbs to help cut the tissue segment off the shaft. The variable aperture can formed by any suitable construction, including a pair of metal plates with matching edges that each define one half of a central opening. The two pieces may be held apart by springs. The aperture may be closed by pushing the two edges together. In other embodiments, this process can be mechanically automated by using a disc or plate with an opening that is adjustable by a variety of known techniques, including a slit screw assembly or flexible gaskets. - Alternative Tissue Excision Devices
- Other cutting and/or grasping devices can be used in place of the system described above. For example, embodiments of the grasping mechanism include but are not limited to: needles with flexible barbs, needles with rigid barbs, corkscrew-shaped needles, and/or retaining wires. The corkscrew-shaped needle shown in
FIG. 19 works by screwing into the ligamentum flavum in the manner that a corkscrew is inserted in a cork. After the screw engages a segment of tissue, outer cuttingelement 60 slides over the needle, cutting a segment of tissue in a manner similar to that of the previous embodiment. In some embodiments, the cutting element can be rotated as it cuts. - In other embodiments, shown in
FIGS. 20-22 , cannulatedscalpel 51 houses a graspingdevice 70 that includes at least one pair of arcuate,closable arms 72.Closable arms 72 may be constructed in any suitable manner. One technique for creating closable arms is to provide a slottedsleeve 74, as shown. Slottedmember 74 preferably comprises anelongate body 75 with at least oneslot 76 that extends through its thickness but does not extend to either end of the body.Slot 76 is preferably parallel to the longitudinal axis of the sleeve. On either side ofslot 76, astrip 77 is defined, withstrips 77 being joined at each end ofsleeve 74. It is preferred that the width of eachstrip 77 be relatively small. In some embodiments, it may be desirable to construct slottedmember 74 from a portion of a hollow tube or from a rectangular piece that has been curved around a longitudinal axis. The inner edge of each strip that lies alongslot 76 forms an opposingedge 78. The width of the piece is the total of the width ofstrips 77 andslot 76. - Advancing one end of
sleeve 74 toward the other end ofsleeve 74 causes eachstrip 77 to buckle or bend. Ifstrips 77 are prevented from buckling inward or if they are predisposed to bend in the desired direction, they will bend outward, thereby formingarcuate arms 72, which extend throughaperture 52 of cannulatedscalpel 51, as shown inFIG. 21 . As they move away from the axis ofbody 75,arms 72 move apart in a direction normal to the axis ofbody 75. Likewise, moving the ends ofsleeve 74 apart causesarms 72 to straighten and to move together and inward toward the axis of the device, as shown inFIG. 22 . As the arms straighten, opposingedges 78 close and a segment of tissue can be capture between them. Tissue within the grasping device may then be resected or anchored via the other mechanisms described herein. -
Closable arms 72 may include on their opposingedges 78 ridges, teeth, or other means to facilitate grasping of the tissue. In other embodiments, edges 78 may be sharpened, so as to excise a segment of tissue as they close. In these embodiments,closable arms 72 may also be used in conjunction with a hook, barbed needle, pincers or the like, which can in turn be used to retrieve the excised segment from the device. - Once
arms 72 have closed on the tissue, ifarms 72 have not cut the tissue themselves, the tissue can be excised using a blade such as cuttingelement 60 above. The excised tissue can be removed from the inside ofneedle 51 using a tissue-engaginghook 64 or other suitable means. The process of extending and closingarms 72, excising the tissue, and removing it from the device can be repeated until a desired amount of tissue has been removed. - If desired, this cycle can be repeated without repositioning the device in the tissue. Alternatively, the tool can be rotated or repositioned as desired between excisions. It is possible to rotate or reposition the tool during an excision, but it is expected that this will not generally be preferred. Furthermore, it is expected that the steps of tissue excision and removal can be accomplished without breaching the surface of the ligament, i.e. without any part of the device entering the safety zone created by the injected fluid. Nonetheless, should the tool leave the working zone, the safety zone will reduce the risk of injury to the thecal sac.
- Ligament Retraction
- In some embodiments, the spinal canal may also be enlarged by retracting the ligamentum flavum, either with or without concurrent resection. Retraction is preferably but not necessarily performed after dural compression has been used to provide a safety zone. In addition, the dural compression techniques described above have the effect of pressing the ligamentum flavum back out of the spinal canal and thereby making it easier to apply a restraining means thereto.
- Thus, in preferred embodiments, after a safety zone is created by epidural injection of contrast medium or gel, a
retraction device 90 as shown inFIG. 23 is used to retract and compress the thickened soft tissues around the posterior aspect of the spinal canal, thereby increasing the available space for the dural sac and nerves. In the embodiment shown,retraction device 90 is a double-headed anchor that includes at least one distal retractable tissue-engagingmember 91 and at least one proximal tissue-engagingmember 92, each of which are supported on abody 94.Retraction device 90 is preferably constructed from an implantable, non-biodegradable material, such as titanium or stainless steel, but may alternatively be polymeric or any other, suitable material. In certain preferred embodiments,body 94 is somewhat flexible. In some instances, flexibility inbody 94 may facilitate the desired engagement ofbarbs Barbs Barbs barbs -
FIG. 23 shows schematically the distal and proximalretractable arms preferred ligament anchor 90. The proximal end of the anchor preferably includes a threaded connector 96 or other releasable mechanism that attaches to asupport rod 100.Ligament anchor 90 may be attached to asupport shaft 112 and sheathed in aguide housing 114. The distal andproximal barbs guide housing 114 from engaging surrounding tissue. Housing 102 is preferably a metal or durable plastic guide housing. - The distal end of the device is preferably positioned in the ligamentum flavum under fluoroscopic guidance. If desired, an accessway through the lamina may be provided using an anchored cannula or the like. The device is held in position by
support shaft 112.Distal barbs 91 are unsheathed and optionally expanded by pulling back guide housing 102, as shown inFIG. 23 .Distal barbs 91 are secured in the ligamentum flavum by pulling back on thesupport shaft 112. Withbarbs 91 engaging the tissue, the ligamentum flavum is retracted posteriorly by pulling back onsupport shaft 112. While maintaining traction on the now-retracted ligament,proximal barbs 92 are uncovered and expanded by retractingguide housing 114, as shown inFIG. 24 .Barbs 92 are preferably positioned in thesoft tissues 116 in the para-spinal region so that the device is firmly anchored behind the posterior elements of the spinal canal. Once the proximal end of the anchor is engaged,support shaft 112 may be detached frombody 94 as shown inFIG. 24 . In this manner, the posterior margin 95 of the ligamentum flavum can be held in a retracted position, thereby expanding the canal. The procedure can then be repeated on adjacent portions of the ligamentum flavum until it is sufficiently retracted. - In an alternative embodiment the proximal end of
ligament anchor 90 may be adapted to engage the lamina. This may be accomplished by having the arm posterior to the lamina or by using the laminotomy and suturing the device to the lamina there. A knotted or knotless system or a suture plate can be used. - A second embodiment of the present method uses a plurality of
retraction devices 90. In this embodiment, the retraction device is inserted through one lamina in an oblique fashion, paralleling the opposite lamina. After the distal anchor is deployed, the retraction device is pulled back and across the ligamentum flavum, thereby decompressing the opposite lateral recess of the spinal canal. This is repeated on the opposite side. This same device can also be deployed with a direct approach to the lateral recess with a curved guide housing. - While
retraction device 90 is describe above as a double-headed anchor, it will be understood that other devices can be used. For example sutures, barbed sutures, staples or the like can be used to fasten the ligament in a retracted position that reduces stenosis. - Using the percutaneous methods and devices described herein, significant reductions of stenosis can be achieved. For example, a dural sac cross-sectional area less than 100 mm2 or an anteroposterior (AP) dimension of the canal of less than 10-12 mm in an average male is typically considered relative spinal stenosis. A dural sac cross-sectional area less than 85 mm2 in an average male is considered severe spinal stenosis. The present devices and techniques are anticipated to cause an increase in canal area of 25 mm2 per anchor or 50 mm2 total. With resection and/or retraction of the ligamentum flavum, the cross-sectional area of the dural sac can be increased by 10 mm2, and in some instances by as much as 20 mm2 or even 30 mm2. Likewise, the present invention can result in an increase of the anteroposterior dimension of the canal by 1 to 2 mm and in some instances by as much as 4 or 6 mm. The actual amount by which the cross-sectional area of the thecal sac and/or the anteroposterior dimension of the canal are increased will depend on the size and age of the patient and the degree of stenosis and can be adjusted by the degree of retraction of the ligament.
- Mild
- The minimally invasive ligament decompression (MILD) devices and techniques described herein allow spinal decompression to be performed percutaneously, avoiding the pain and risk associated with open surgery. Through the provision of a safety zone, the present devices and techniques offer reduced risk of spinal cord damage. In addition to improving nerve function, it is expected that decompression of the spinal canal in the manner described herein will result in improved blood flow to the neural elements by reducing the extrinsic pressure on the spinal vasculature. For these reasons, it is believed that spinal decompression performed according to the present invention will be preferable to decompression operations performed using currently known techniques.
- Dural Shield
- In some embodiments (not shown), a mechanical device such as a balloon or mechanical shield can also be used to create a protective guard or barrier between the borders of the epidural space and the adjacent structures. In one embodiment a durable expandable device is attached to the outside of the percutaneous laminectomy device, preferably on the side opposite the cutting aperture. The cutting device is inserted into the ligamentum flavum with the expandable device deflated. With the aperture directed away from the spinal canal, the expandable device is gently expanded via mechanical means or inflated with air or another sterile fluid, such as saline solution, via a lumen that may be within or adjacent to the body of the device. This pushes the adjacent vital structures clear from the cutting aperture of the device and simultaneously presses the cutting aperture into the ligament. As above, the grasping and cutting needles can then be deployed and operated as desired. The balloon does not interfere with tissue excision because it is located on the side opposite the cutting aperture. The cutting needle may be hemispherical (semi-tubular) in shape with either a straight cutting or a sawing/reciprocating blade or may be sized to be placed within the outer housing that separates the balloon from the cutting aperture.
- In another embodiment, a self-expanding metal mesh is positioned percutaneously in the epidural space. First the epidural space is accessed in the usual fashion. Then a guide catheter is placed in the epidural space at the site of the intended surgical procedure. The mesh is preferably compressed within a guide catheter. When the outer cover of the guide catheter is retracted, the mesh expands in the epidural space, protecting and displacing the adjacent dural sheath. At the conclusion of the surgical procedure, the mesh is pulled back into the guide sheath and the assembly removed. The mesh is deformable and compresses as it is pulled back into the guide catheter, in a manner similar to a self-expanding mesh stent. There are many commercially available self-expanding stents approved and in use in other applications. However, using a self-expandable mesh as a device within the epidural space to protect and displace the thecal sac is novel.
- Tissue Excision Devices
- Embodiments of tissue excision tools, devices, and methods disclosed herein may take several forms and may be used in accordance with the MILD method described above, or used according to alternative procedures such as the ipsilateral approach minimally invasive ligament decompression procedure (ILAMP method) disclosed in U.S. application Ser. No. 11/382,349, which is hereby incorporated herein by reference in its entirety.
- In the descriptions of the tissue excision devices below, the distal portions of the devices are described in detail, distal referring to positions that are relatively closer to the region of interest (e.g., the thickened portion of the ligamentum flavum to be decompressed). An exemplary embodiment of a proximal end for the tissue excision devices, including an actuation means, is also described below. However, it is to be understood that embodiments of tissue extraction devices described herein may be used with a variety of proximal ends and a variety of actuation means that are known and understood by those skilled in the art.
-
FIGS. 31-33 illustrate the distal portion of an embodiment of atissue excision device 200 in an open position.Tissue excision device 200 comprises aninner tubular 230 coaxially disposed within and slidingly engaging anouter sleeve 210.Inner tubular 230 andsleeve 210 both share a centrallongitudinal axis 250.Sleeve 210 has an inner radius R1 (not shown), as measured fromaxis 250, andinner tubular 230 has an outer radius R2 (not shown), as measured fromaxis 250. In this embodiment, outer radius R2 is substantially the same or slightly less than inner radius R1 such that the outer surface of inner tubular 230 slidingly engages the inner surface ofsleeve 210. Thus,sleeve 210 andinner tubular 230 are permitted to move axially (i.e., along axis 250) relative to each other.Sleeve 210 andinner tubular 230 may be formed from any suitable hollow bodies including without limitation a hypotube, cannula, or catheter. Althoughsleeve 210 and inner tubular 230 shown inFIGS. 31-33 generally have a circular cross-section, ingeneral sleeve 210 andinner tubular 230 may have any suitable shape and cross-section including without limitation circular, oval, or rectangular. - Inner tubular 230 includes a central cavity or through bore 240 (
FIG. 32 ) that runs the length ofinner tubular 230. In addition, a cuttinghead 250 is disposed at the distal end ofinner tubular 230. In this embodiment, cuttinghead 250 is formed integrally with inner tubular 230 such as by casting, molding, or machining. However, in different embodiments, cuttinghead 250 may be manufactured separately frominner tubular 230 and then fixed to the distal end of inner tubular 230 by any suitable means, such as welding. - Cutting
head 250 preferably comprises abody 252 and three cuttingarms 253 extending axially frombody 252. In this embodiment,body 252 is integral with and essentially an extension ofinner tubular 230. Since eacharm 253 extends axially frombody 252, eacharm 253 may be described as including a fixed end 253 a integral withbody 252 and afree end 253 b generally distal tobody 252. Although each of the embodiments illustrated herein show cuttinghead 250 with three cuttingarms 253, in different embodiments, cuttinghead 250 may include any suitable number of cuttingarms 253 including without limitation two, three, four, or more. -
Arms 253 are preferably integral withbody 252 andinner tubular 230. In such embodiments,arms 253 may be formed by any suitable means including without limitation casting or molding, laser cutting, machining, or combinations thereof. However, it should be understood thatarms 253 may alternatively be distinct components that are mechanically coupled tobody 252 and inner tubular 230 generally at fixed end 253 a. In such alternative embodiments,arms 253 may be connected toinner tubular 230 by any suitable means, including without limitation welding, pins, or combinations thereof. - As best shown in
FIG. 32 , bore 240 is contiguous with a tissue-receivingspace 263 defined betweenarms 253 inside cuttinghead 250. Tissue-receivingspace 253 and bore 240 accommodate tissue excised by device 200 (e.g., excised pieces of ligamentum flavum). In some embodiments, one or more of the surfaces that define tissue-receivingspace 263 inside cuttinghead 250 may include ridges, knurling or other textured surface features 264 thereon so as to further improve grasping and retention of tissue betweenarms 253.Textured surface feature 264 may be formed by any suitable means including without limitation knurling, sand blasting, bead blasting, plasma etching, or combinations thereof. Likewise, the inner surface of inner tubular 230 may be roughened to enhance the ability ofinner bore 240 to enhance grasping and retention of excised portions of tissue. - Referring again to
FIGS. 31-33 , eacharm 253 preferably terminates in a cutting or tissue-grasping member. In the embodiment shown inFIGS. 31 and 32 , two aims terminate incutters 251 and a third arm terminates in a sharp anchoring tip 154 that extends beyond the distal ends ofcutters 251. Eachcutting edge 251 preferably has a sharpened or beveled edge adapted to slice through tissue. In addition, in this embodiment, anchoring tip 254 includes atissue grasping member 257 that extends radially inward and helps grasp tissue and retain tissue within tissue-receivingspace 263. In this embodiment,tissue grasping member 257 is a tooth. However, in different embodiments, one or more tissue grasping members may comprise teeth, barbs, or the like.Tooth 257 preferably has sharpened edges to enhance cutting of tissue. In general,arms 253 may be any desired length. - Cutting
head 250 is constructed so thatarms 253 can be brought together so as to grasp tissue therebetween, termed herein as a “closed position”, and moved apart so as to release tissue and/or allow the entry of tissue betweenarms 253, termed herein as an “open position”. As shown inFIGS. 31 and 32 , cuttinghead 250 is in an open position. Specifically when cuttinghead 250 is in an open position, cuttinghead 250 is extended fromsleeve 210 andfree ends 253 b of eacharm 253 are radially spaced apart. Consequently, any tissue within tissue-receivingspace 263 is not pinched or firmly grasped byarms 253 and tissue is allowed to enter tissue-receivingspace 263 via the gap betweenfree ends 253 b ofarms 253. - Referring now to
FIGS. 31 and 33 , cuttinghead 250 is transitioned to a closed position by advancingsleeve 210 axially relative to cuttinghead 250 toward cutting ends 253 b ofarms 253 in the direction ofarrow 270. Specifically, eacharm 253 preferably includes afrustoconical chamfer 255 on its outer surface. The surface of eachfrustoconical chamfer 255 extends radially beyond inner radius R1 ofsleeve 210. In the opened position (FIG. 31 ), cuttinghead 250 is extended fromsleeve 210 and thussleeve 210 does not engagefrustoconical chamfer 255. Thus, eachfrustoconical chamfer 255 is generally flee to extend radially beyond inner radius R1 of sleeve 210 (i.e.,sleeve 210 does engagechamfers 255 nor restrict arms 253). However, whensleeve 210 is advanced toward cutting ends 253 b it engages the portions offrustoconical chamfer 255 that radially extend beyond inner radius R1 ofsleeve 210, thereby tending to forcearms 253 together. Assleeve 210 is advanced further towards cutting ends 253 b,sleeve 210 continues to bear onchamfers 255 andarms 253 are brought closer together. Cuttinghead 250 achieves the closed position whenarms 253 contact each other and/or when each radially outermost portions orridge 260 of eachfrustoconical chamfer 255 is disposed withininner tubular 230. At this point, cutting ends 253 b of eacharm 253 are at their closest relative to each other. In some embodiments, cutting ends 253 b may engage adjacent cutting ends 253 b. - In the reverse manner,
device 200 and cuttinghead 250 can be transitioned from the closed position to the open position. In general,sleeve 210 may be moved axially relative to cuttinghead 250 by any suitable manner including without limitation a threaded engagement withinner tubular 230, a trigger mechanism, or combinations thereof. - In the embodiments described herein, aims 253 are normally open. In other words,
arms 253 are biased to the open position such that cuttinghead 250 will assume the open position when no forces are acting to push arms 153 together. Thus, to transitiondevice 200 and cuttinghead 250 to the closed position, compressive forces, namelysleeve 210 acting on eachfrustoconical chamfer 255, are necessary to pushaims 253 together. Further, sincearms 253 are biased open, cuttinghead 253 will automatically assume the open position illustrated inFIG. 31 assleeve 210 is retracted and cuttinghead 253 extendsflom sleeve 210. However, in other embodiments (not illustrated),arms 253 may be biased closed and transitioned to an open position by providing an inner wedge between eacharm 253 that urges the arms apart as it moves axially relative toarms 253. - Tissue Excision and Removal
-
FIGS. 34 and 35 schematically illustrate the excision of a portion oftissue 126 bydevice 200. In some embodiments, a portal or cannula (not shown) may be employed to provide percutaneous access totissue 126. For instance,tissue excision device 200 may be inserted into and advanced through such a portal or cannula to reachtissue 126. U.S. application Ser. No. 11/461,020 filed concurrently herewith, which is hereby incorporated herein by reference in its entirety, discloses several tools, devices and methods for employing a portal to provide percutaneous access to a tissue of interest. If a portal or cannula is used to guidedevice 200,device 200 may be passed through such cannula in the opened position or closed position. - Regardless of the manner in which
tissue excision device 200 reaches the tissue of interest (e.g., by portal or otherwise), prior to insertion into the tissue to be excised,device 200 is configured in the open position as shown inFIGS. 31 and 32 . Withdevice 200 in the opened position, the distal portion oftissue excision device 200 is advanced intotissue 126, as best shown inFIG. 34 .Tissue 126 may be any type of tissue to be excised and removed from a patient including without limitation, soft tissue, fat, muscle, or bone. When used to treat spinal stenosis caused by a thickened ligamentum flavum, cuttinghead 250 ofdevice 200 is preferably inserted into thestenotic ligamentum flavum 26, preferably posterior to asafety zone 40, in order to safely cut and remove portions of the thickened ligamentum flavum 26 (seeFIGS. 2 and 3 ), thereby reducing the stenosis. - Still referring to
FIGS. 34 and 35 , asdevice 200 is inserted and advanced intotissue 126, portions oftissue 126 slide into and fill at least a portion of tissue-receivingspace 263 betweenarms 253 within cuttinghead 250. It is to be understood that thefarther device 200 is advanced intotissue 126, the greater the amount oftissue 126 that will occupy tissue-receivingspace 263. As tissue-receivingspace 263 fills, some excess tissue within tissue-receivingspace 263 may be pushed intobore 240 ofinner tubular 230.Arms 253 are preferably rigid such that cuttinghead 250 does not inadvertently transition to the closed position asdevice 200 is advanced through the tissue. In other words,arms 253 are preferably rigid so that the forces exerted on the outer surface ofarms 253 by the surroundingtissue 126 asdevice 200 is advanced do not tend to movearms 253 towards each other. - Once a desired amount of tissue has filled tissue-receiving
space 263 and bore 240,device 200 may be transitioned to the closed position by advancingsleeve 210 toward cutting ends 253 b and over cuttinghead 250 as previously described. Asarms 253 move towards each other, the portions oftissue 126 within tissue-receivingspace 263 and bore 240 are severed from the surroundingtissue 126. Specifically, the sharpened or beveled edges ofcutters 251 andtooth 257 slice tissue extending axially from tissue-receivingspace 263, while an annular cutting edge 211 ofsleeve 210 slices tissue extending radially from tissue-receivingspace 263 betweenarms 253. Cutting edge 211 ofsleeve 210 is preferably sharpened to enhance the cutting ability ofsleeve 210 as it moves relative to cuttinghead 250. In addition, the severedtissue 126 contained within tissue-receivingspace 263 is grasped byarms 253. Specifically,arms 253 exert compressive forces on thetissue 126 within tissue-receivingspace 263, the textured surface features 264 on the inner surface ofarms 253 grips thetissue 126 within tissue-receivingspace 263, andtooth 257 graspstissue 126 within tissue-receivingspace 263 and restricts it from sliding axially out of cuttinghead 250 between cutting ends 253 b. - Once
device 200 has achieved the closed position,device 200 maybe retracted fromtissue 126 as best shown inFIG. 35 . The portion oftissue 126 contained within tissue-receivingspace 263 and bore 240 is removed along withdevice 200. Oncedevice 200, including a portion oftissue 126 within tissue-receivingspace 263 and bore 240, has been completely removed from the patient, resected tissue within tissue-receivingspace 263 and bore 240 is removed fromdevice 200 so thatdevice 200 may be reinserted intotissue 126 to continue to the cutting and removal of portions oftissue 126. - Pieces of
tissue 126 captured within tissue-receivingspace 263 and bore 240 may be removed by simply openingdevice 200 and pulling the pieces of tissue from tissue-receivingspace 263 and bore 240.Device 200 may be opened from the closed position by retractingsleeve 210 from cuttinghead 250 as previously described. Asdevice 200 transitions to its opened position,arms 253 will separate, allowing the user to access tissue-receivingspace 263 andinner bore 240. - In an alternative embodiment, a plunger or tissue ejector may be included with
device 200 to physically eject the excisedtissue 126 from tissue-receivingspace 263 andinner bore 240. For instance, a plunger (not shown) may be included withindevice 200 to push cut tissue in tissue-receivingspace 263 andinner bore 240 axially out through the opening between cutting ends 253 b ofarms 253. - The process of inserting
device 200 intotissue 126 in the opened position, closingdevice 126, retractingdevice 200 in the closed position,opening device 200, emptying tissue-receivingspace 263 and bore 240, and reinsertingdevice 200 may be repeated until the desired amount oftissue 126 has been excised and removed. Referring briefly toFIG. 3 , whendevice 200 is employed to remove portions of thickened ligamentum flavum 26, this process may be repeated until the spinal canal is adequately decompressed. Further, whendevice 200 is employed to remove portions of thickened ligamentum flavum 26, the cutting ends 253 b of eacharm 253 ofdevice 200 are preferably controlled to remain within ligamentum flavum 26 and not penetratesafety zone 40. Nonetheless,safety zone 40 is preferably provided so that even an inadvertent penetration intoepidural space 27 bydevice 200 will not result in damage to thedural sac 32 ornerves 34. - The components of tissue excision device 200 (e.g.,
arms 253,tooth 257, etc.) may comprise any suitable material(s) including without limitation metals (e.g., stainless steel, titanium, etch), non-metals (e.g., polymer, composites, etc.) or combinations thereof. The components oftissue excision device 200 are preferably manufactured from a durable biocompatible material such as titanium or stainless steel, but may alternatively be polymeric. In addition,arms 253 each preferably comprise a relatively rigid material(s) capable of maintaining their shape and configuration when inserted into and advanced through tissue. Further,arms 253 preferably comprises a resilient material having the ability to be repeatedly flexed between the open position and closed position without cracking or otherwise being damaged. Such a resilient material also enables eacharm 253 to return to its original configuration once external forces (e.g., force applied by sleeve 210) are removed. - In addition, the components of
tissue excision device 200 may be manufactured by any suitable methods. Examples of suitable methods include casting or molding, machining, laser cutting, EMD, or combinations thereof. In some embodiments, cutting edges or tips may be electro polished to for sharpening. The components oftissue excision device 200 may be assembled by any suitable method including without limitation welding, press fitting, or combinations thereof. - While preferred embodiments of this invention have been shown and described, modifications thereof can be made by one skilled in the art without departing from the scope or teaching of this invention. For example, the means by which the safety zone is formed may be varied, the shape and configuration of the tissue excision devices may be varied, and the steps used in carrying out the technique may be modified. Accordingly, the invention is not limited to the embodiments described herein, but is only limited by the claims that follow, the scope of which shall include all equivalents of the subject matter of the claims. Likewise, the sequential recitation of steps in a claim, unless explicitly so stated, is not intended to require that the steps be performed in any particular order or that a particular step be completed before commencement of another step.
Claims (17)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/461,036 US20070027464A1 (en) | 2005-07-29 | 2006-07-31 | Device for resecting spinal tissue |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70422405P | 2005-07-29 | 2005-07-29 | |
US74716606P | 2006-05-12 | 2006-05-12 | |
US11/461,036 US20070027464A1 (en) | 2005-07-29 | 2006-07-31 | Device for resecting spinal tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070027464A1 true US20070027464A1 (en) | 2007-02-01 |
Family
ID=37709378
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/461,036 Abandoned US20070027464A1 (en) | 2005-07-29 | 2006-07-31 | Device for resecting spinal tissue |
US11/461,045 Active 2028-11-20 US8696671B2 (en) | 2005-07-29 | 2006-07-31 | Percutaneous tissue excision devices |
US14/019,135 Active US8894653B2 (en) | 2005-07-29 | 2013-09-05 | Percutaneous tissue excision devices and methods |
US14/032,770 Active US8882772B2 (en) | 2005-07-29 | 2013-09-20 | Percutaneous tissue excision devices and methods |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/461,045 Active 2028-11-20 US8696671B2 (en) | 2005-07-29 | 2006-07-31 | Percutaneous tissue excision devices |
US14/019,135 Active US8894653B2 (en) | 2005-07-29 | 2013-09-05 | Percutaneous tissue excision devices and methods |
US14/032,770 Active US8882772B2 (en) | 2005-07-29 | 2013-09-20 | Percutaneous tissue excision devices and methods |
Country Status (8)
Country | Link |
---|---|
US (4) | US20070027464A1 (en) |
EP (3) | EP3228265A3 (en) |
JP (1) | JP2009502365A (en) |
AT (1) | ATE495701T1 (en) |
CA (1) | CA2614721A1 (en) |
DE (1) | DE602006019736D1 (en) |
ES (1) | ES2637638T3 (en) |
WO (2) | WO2007016683A2 (en) |
Cited By (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040267269A1 (en) * | 2001-06-01 | 2004-12-30 | Middleton Lance M. | Tissue cavitation device and method |
US20060036272A1 (en) * | 2004-07-29 | 2006-02-16 | X-Sten, Inc. | Spinal ligament modification |
US20060258951A1 (en) * | 2005-05-16 | 2006-11-16 | Baxano, Inc. | Spinal Access and Neural Localization |
US20070055215A1 (en) * | 2005-07-29 | 2007-03-08 | X-Sten Corp. | Percutaneous Tissue Excision Devices and Methods |
US20070055263A1 (en) * | 2005-07-29 | 2007-03-08 | X-Sten Corp. | Tools for Percutaneous Spinal Ligament Decompression and Device for Supporting Same |
US20070123890A1 (en) * | 2005-11-04 | 2007-05-31 | X-Sten, Corp. | Tissue retrieval devices and methods |
US20070123877A1 (en) * | 2005-11-15 | 2007-05-31 | Aoi Medical, Inc. | Inflatable Device for Restoring Anatomy of Fractured Bone |
US20070213735A1 (en) * | 2004-10-15 | 2007-09-13 | Vahid Saadat | Powered tissue modification devices and methods |
US20070260252A1 (en) * | 2006-05-04 | 2007-11-08 | Baxano, Inc. | Tissue Removal with at Least Partially Flexible Devices |
US20070276390A1 (en) * | 2006-05-09 | 2007-11-29 | X-Sten, Inc. | Ipsilateral Approach to Minimally Invasive Ligament Decompression Procedure |
US20080033465A1 (en) * | 2006-08-01 | 2008-02-07 | Baxano, Inc. | Multi-Wire Tissue Cutter |
US20080086034A1 (en) * | 2006-08-29 | 2008-04-10 | Baxano, Inc. | Tissue Access Guidewire System and Method |
US20080091227A1 (en) * | 2006-08-25 | 2008-04-17 | Baxano, Inc. | Surgical probe and method of making |
US20080111101A1 (en) * | 2006-11-09 | 2008-05-15 | Jason Keleher | Compositions and methods for CMP of low-k-dielectric materials |
US20080147084A1 (en) * | 2006-12-07 | 2008-06-19 | Baxano, Inc. | Tissue removal devices and methods |
US20080161809A1 (en) * | 2006-10-03 | 2008-07-03 | Baxano, Inc. | Articulating Tissue Cutting Device |
US20080221383A1 (en) * | 2007-02-12 | 2008-09-11 | Vertos Medical, Inc. | Tissue excision devices and methods |
US20080275458A1 (en) * | 2004-10-15 | 2008-11-06 | Bleich Jeffery L | Guidewire exchange systems to treat spinal stenosis |
US20080294167A1 (en) * | 2007-05-21 | 2008-11-27 | Brian Schumacher | Articulating cavitation device |
US20080312660A1 (en) * | 2007-06-15 | 2008-12-18 | Baxano, Inc. | Devices and methods for measuring the space around a nerve root |
US20090018507A1 (en) * | 2007-07-09 | 2009-01-15 | Baxano, Inc. | Spinal access system and method |
US20090118709A1 (en) * | 2007-11-06 | 2009-05-07 | Vertos Medical, Inc. A Delaware Corporation | Tissue Excision Tool, Kits and Methods of Using the Same |
US20090149865A1 (en) * | 2007-12-07 | 2009-06-11 | Schmitz Gregory P | Tissue modification devices |
US20090171381A1 (en) * | 2007-12-28 | 2009-07-02 | Schmitz Gregory P | Devices, methods and systems for neural localization |
US20090177241A1 (en) * | 2005-10-15 | 2009-07-09 | Bleich Jeffery L | Multiple pathways for spinal nerve root decompression from a single access point |
USD610259S1 (en) | 2008-10-23 | 2010-02-16 | Vertos Medical, Inc. | Tissue modification device |
USD611146S1 (en) | 2008-10-23 | 2010-03-02 | Vertos Medical, Inc. | Tissue modification device |
USD619252S1 (en) | 2008-10-23 | 2010-07-06 | Vertos Medical, Inc. | Tissue modification device |
USD619253S1 (en) | 2008-10-23 | 2010-07-06 | Vertos Medical, Inc. | Tissue modification device |
USD620593S1 (en) | 2006-07-31 | 2010-07-27 | Vertos Medical, Inc. | Tissue excision device |
USD621939S1 (en) | 2008-10-23 | 2010-08-17 | Vertos Medical, Inc. | Tissue modification device |
US20100321426A1 (en) * | 2007-11-22 | 2010-12-23 | Kazuki Suzuki | Image forming apparatus |
US20100331883A1 (en) * | 2004-10-15 | 2010-12-30 | Schmitz Gregory P | Access and tissue modification systems and methods |
US20100331900A1 (en) * | 2009-06-25 | 2010-12-30 | Baxano, Inc. | Surgical tools for treatment of spinal stenosis |
US7887538B2 (en) | 2005-10-15 | 2011-02-15 | Baxano, Inc. | Methods and apparatus for tissue modification |
USD635671S1 (en) | 2008-10-23 | 2011-04-05 | Vertos Medical, Inc. | Tissue modification device |
US20110112539A1 (en) * | 2008-07-14 | 2011-05-12 | Wallace Michael P | Tissue modification devices |
US7959577B2 (en) | 2007-09-06 | 2011-06-14 | Baxano, Inc. | Method, system, and apparatus for neural localization |
US20110160731A1 (en) * | 2004-10-15 | 2011-06-30 | Bleich Jeffery L | Devices and methods for tissue access |
US20110224710A1 (en) * | 2004-10-15 | 2011-09-15 | Bleich Jeffery L | Methods, systems and devices for carpal tunnel release |
US8048080B2 (en) | 2004-10-15 | 2011-11-01 | Baxano, Inc. | Flexible tissue rasp |
US8062298B2 (en) | 2005-10-15 | 2011-11-22 | Baxano, Inc. | Flexible tissue removal devices and methods |
US8142462B2 (en) | 2004-05-28 | 2012-03-27 | Cavitech, Llc | Instruments and methods for reducing and stabilizing bone fractures |
US8221420B2 (en) | 2009-02-16 | 2012-07-17 | Aoi Medical, Inc. | Trauma nail accumulator |
US8366712B2 (en) | 2005-10-15 | 2013-02-05 | Baxano, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US8398641B2 (en) | 2008-07-01 | 2013-03-19 | Baxano, Inc. | Tissue modification devices and methods |
US8409206B2 (en) | 2008-07-01 | 2013-04-02 | Baxano, Inc. | Tissue modification devices and methods |
US8430881B2 (en) | 2004-10-15 | 2013-04-30 | Baxano, Inc. | Mechanical tissue modification devices and methods |
US8579902B2 (en) | 2004-10-15 | 2013-11-12 | Baxano Signal, Inc. | Devices and methods for tissue modification |
US8647346B2 (en) | 2004-10-15 | 2014-02-11 | Baxano Surgical, Inc. | Devices and methods for tissue modification |
US8801626B2 (en) | 2004-10-15 | 2014-08-12 | Baxano Surgical, Inc. | Flexible neural localization devices and methods |
US20140276802A1 (en) * | 2013-03-14 | 2014-09-18 | Kyphon Sarl | Rotatable cutting instrument and method |
US9101386B2 (en) | 2004-10-15 | 2015-08-11 | Amendia, Inc. | Devices and methods for treating tissue |
US9314253B2 (en) | 2008-07-01 | 2016-04-19 | Amendia, Inc. | Tissue modification devices and methods |
US9414884B2 (en) | 2011-07-22 | 2016-08-16 | Martin Faehndrich | Instrument set for treating stenoses of the spinal canal |
WO2016154030A1 (en) * | 2015-03-20 | 2016-09-29 | Musc Foundation For Research Development | Dural protecting rongeur |
US9456829B2 (en) | 2004-10-15 | 2016-10-04 | Amendia, Inc. | Powered tissue modification devices and methods |
CN106137268A (en) * | 2016-08-26 | 2016-11-23 | 南京微创医学科技股份有限公司 | A kind of ultrasonic sampling probe |
EP3038548A4 (en) * | 2013-08-31 | 2017-08-23 | Robert Peliks | Tissue removal device and method of use |
US9763648B2 (en) | 2013-08-31 | 2017-09-19 | Becton, Dickerson and Company | Tissue removal device and method of use |
US20180014837A1 (en) * | 2016-07-13 | 2018-01-18 | Washington University | Discectomy instrument |
US20210212832A1 (en) * | 2015-04-14 | 2021-07-15 | Cartiva, Inc. | Tooling for creating tapered opening in tissue and related methods |
WO2022244711A1 (en) * | 2021-05-18 | 2022-11-24 | オリンパス株式会社 | Biopsy device and specimen sampling device |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10154163A1 (en) | 2001-11-03 | 2003-05-22 | Advanced Med Tech | Device for straightening and stabilizing the spine |
US8273108B2 (en) | 2004-10-20 | 2012-09-25 | Vertiflex, Inc. | Interspinous spacer |
US9161783B2 (en) | 2004-10-20 | 2015-10-20 | Vertiflex, Inc. | Interspinous spacer |
US7763074B2 (en) | 2004-10-20 | 2010-07-27 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
US8128662B2 (en) | 2004-10-20 | 2012-03-06 | Vertiflex, Inc. | Minimally invasive tooling for delivery of interspinous spacer |
US8317864B2 (en) | 2004-10-20 | 2012-11-27 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
US8152837B2 (en) | 2004-10-20 | 2012-04-10 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
US8167944B2 (en) | 2004-10-20 | 2012-05-01 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for posterior dynamic stabilization of the spine |
US9119680B2 (en) | 2004-10-20 | 2015-09-01 | Vertiflex, Inc. | Interspinous spacer |
US9023084B2 (en) | 2004-10-20 | 2015-05-05 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for stabilizing the motion or adjusting the position of the spine |
US8409282B2 (en) | 2004-10-20 | 2013-04-02 | Vertiflex, Inc. | Systems and methods for posterior dynamic stabilization of the spine |
EP2219538B1 (en) | 2004-12-06 | 2022-07-06 | Vertiflex, Inc. | Spacer insertion instrument |
JP4679320B2 (en) * | 2005-09-26 | 2011-04-27 | タカタ株式会社 | Airbag device, motorcycle with airbag device |
US8845726B2 (en) | 2006-10-18 | 2014-09-30 | Vertiflex, Inc. | Dilator |
JP2010511442A (en) * | 2006-12-01 | 2010-04-15 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | Devices and methods for accessing the epidural space |
US8979931B2 (en) | 2006-12-08 | 2015-03-17 | DePuy Synthes Products, LLC | Nucleus replacement device and method |
WO2008130564A1 (en) | 2007-04-16 | 2008-10-30 | Vertiflex Inc. | Interspinous spacer |
AU2008308426A1 (en) | 2007-10-05 | 2009-04-09 | Synthes Gmbh | Dilation system and method of using the same |
WO2009091922A2 (en) | 2008-01-15 | 2009-07-23 | Vertiflex, Inc. | Interspinous spacer |
US8936598B2 (en) * | 2009-01-14 | 2015-01-20 | DePuy Synthes Products, LLC | Spinal disc preparation tool |
WO2011066470A1 (en) | 2009-11-25 | 2011-06-03 | Clements Robert M | Device and system for multiple core biopsy |
CN103841907B (en) * | 2011-02-15 | 2019-06-14 | 史密夫和内修有限公司 | Arthroscope device for excising |
AU2012323897A1 (en) * | 2011-10-15 | 2014-05-01 | Transmed7, Llc | Soft tissue coring biopsy devices and methods |
US9622779B2 (en) | 2011-10-27 | 2017-04-18 | DePuy Synthes Products, Inc. | Method and devices for a sub-splenius / supra-levator scapulae surgical access technique |
WO2013067179A2 (en) | 2011-11-01 | 2013-05-10 | Synthes Usa, Llc | Dilation system |
US9265490B2 (en) | 2012-04-16 | 2016-02-23 | DePuy Synthes Products, Inc. | Detachable dilator blade |
US9480855B2 (en) | 2012-09-26 | 2016-11-01 | DePuy Synthes Products, Inc. | NIR/red light for lateral neuroprotection |
EP2946732B1 (en) * | 2013-01-21 | 2019-04-17 | FUJIFILM Corporation | Tissue sampling device |
US9675303B2 (en) | 2013-03-15 | 2017-06-13 | Vertiflex, Inc. | Visualization systems, instruments and methods of using the same in spinal decompression procedures |
WO2014192646A1 (en) * | 2013-05-27 | 2014-12-04 | 富士フイルム株式会社 | Tissue sampling device |
US9155527B2 (en) * | 2013-08-22 | 2015-10-13 | Transmed7, Llc | Soft tissue coring biopsy devices and methods |
EP3043719B1 (en) | 2013-09-12 | 2022-04-13 | Transmed7, LLC | Tissue coring biopsy devices |
CN103860211B (en) * | 2014-03-28 | 2015-07-08 | 山东省立医院 | Centrum tumor remover |
CN106470617B (en) * | 2014-05-07 | 2019-11-12 | 波士顿科学国际有限公司 | Endoscopic ultrasonography guided fine needle aspirates (EUS-FNA) anesthesia needle |
AU2015256024B2 (en) | 2014-05-07 | 2020-03-05 | Vertiflex, Inc. | Spinal nerve decompression systems, dilation systems, and methods of using the same |
WO2016019097A1 (en) * | 2014-07-31 | 2016-02-04 | Boston Scientific Scimed, Inc. | Scooper core needle |
US9980737B2 (en) | 2014-08-04 | 2018-05-29 | Medos International Sarl | Flexible transport auger |
US10182797B2 (en) | 2014-08-04 | 2019-01-22 | Aton Holzer | Multi-function dermatological biopsy instrument |
US9883898B2 (en) | 2014-08-07 | 2018-02-06 | Jeffrey Scott Smith | Pedicle screw with electro-conductive coating or portion |
US9924979B2 (en) | 2014-09-09 | 2018-03-27 | Medos International Sarl | Proximal-end securement of a minimally invasive working channel |
US10264959B2 (en) | 2014-09-09 | 2019-04-23 | Medos International Sarl | Proximal-end securement of a minimally invasive working channel |
US10111712B2 (en) | 2014-09-09 | 2018-10-30 | Medos International Sarl | Proximal-end securement of a minimally invasive working channel |
US11172912B2 (en) * | 2014-09-23 | 2021-11-16 | Innovasci Llc | Biopsy needle and medical device incorporating the same |
WO2016141186A1 (en) | 2015-03-03 | 2016-09-09 | Transmed7, Llc | Devices and methods for soft tissue biopsy and tissue sample collection |
US10786264B2 (en) | 2015-03-31 | 2020-09-29 | Medos International Sarl | Percutaneous disc clearing device |
US10485522B2 (en) | 2015-04-28 | 2019-11-26 | Transmed7, Llc | Excisional coring devices and methods for image guided hard and soft tissue biopsy |
US11439380B2 (en) | 2015-09-04 | 2022-09-13 | Medos International Sarl | Surgical instrument connectors and related methods |
US11744447B2 (en) | 2015-09-04 | 2023-09-05 | Medos International | Surgical visualization systems and related methods |
CN113143355A (en) | 2015-09-04 | 2021-07-23 | 美多斯国际有限公司 | Multi-shield spinal access system |
US11672562B2 (en) | 2015-09-04 | 2023-06-13 | Medos International Sarl | Multi-shield spinal access system |
US10987129B2 (en) | 2015-09-04 | 2021-04-27 | Medos International Sarl | Multi-shield spinal access system |
US11033291B2 (en) | 2015-10-02 | 2021-06-15 | Nanice Medical Solutions Llc | Surgical device for use in endoscopic carpal tunnel release (ECTR), endoscopic cubital tunnel release (ECuTR), and endoscopic plantar fasciitis release (EPFR) |
US10806481B2 (en) | 2015-10-02 | 2020-10-20 | Nanice Medical Solutions Llc | Surgical device for use in endoscopic carpal tunnel release (ECTR), endoscopic cubital tunnel release (ECuTR), and endoscopic plantar fasciitis release (EPFR) |
WO2017134649A1 (en) * | 2016-02-02 | 2017-08-10 | Holzer Aton M | Multi-function biopsy sampling instrument |
US10299838B2 (en) | 2016-02-05 | 2019-05-28 | Medos International Sarl | Method and instruments for interbody fusion and posterior fixation through a single incision |
EP3988027A1 (en) | 2016-03-13 | 2022-04-27 | Vuze Medical Ltd. | Apparatus and methods for use with skeletal procedures |
US11744602B2 (en) * | 2017-02-15 | 2023-09-05 | Transmed7, Llc | Advanced minimally invasive multi-functional robotic surgical devices and methods |
USD825058S1 (en) * | 2017-03-23 | 2018-08-07 | Karl Storz Gmbh & Co. Kg | Bipolar Forceps |
USD825057S1 (en) * | 2017-03-23 | 2018-08-07 | Karl Storz Gmbh & Co. Kg | Bipolar forceps |
USD825755S1 (en) * | 2017-03-23 | 2018-08-14 | Karl Storz Gmbh & Co. Kg | Bipolar forceps |
USD825754S1 (en) * | 2017-03-23 | 2018-08-14 | Karl Storz Gmbh & Co. Kg | Bipolar forceps |
WO2019012520A1 (en) | 2017-07-08 | 2019-01-17 | Vuze Medical Ltd. | Apparatus and methods for use with image-guided skeletal procedures |
RU179099U1 (en) * | 2017-10-27 | 2018-04-26 | Максим Николаевич Кравцов | DEVICE FOR PERCUTANEOUS VIDEO-ENDOSCOPIC INTERVENTIONS ON THE SPINE |
US10993737B2 (en) * | 2018-05-23 | 2021-05-04 | Transmed7, Llc | Excisional devices and methods |
US11013530B2 (en) | 2019-03-08 | 2021-05-25 | Medos International Sarl | Surface features for device retention |
US11241252B2 (en) | 2019-03-22 | 2022-02-08 | Medos International Sarl | Skin foundation access portal |
US11129727B2 (en) | 2019-03-29 | 2021-09-28 | Medos International Sari | Inflatable non-distracting intervertebral implants and related methods |
US11813026B2 (en) | 2019-04-05 | 2023-11-14 | Medos International Sarl | Systems, devices, and methods for providing surgical trajectory guidance |
KR102245306B1 (en) * | 2019-05-23 | 2021-04-29 | 고려대학교 산학협력단 | Apparautus for removing malacia prolapsus |
US11771517B2 (en) | 2021-03-12 | 2023-10-03 | Medos International Sarl | Camera position indication systems and methods |
USD1002847S1 (en) | 2021-08-28 | 2023-10-24 | Orange Llc | Precision cutting tool |
Citations (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1493240A (en) * | 1923-02-15 | 1924-05-06 | Frank J Bohn | Surgical bone cutter and extractor |
US3893445A (en) * | 1974-01-09 | 1975-07-08 | Becton Dickinson Co | Bone marrow biopsy instrument |
US3989033A (en) * | 1973-12-06 | 1976-11-02 | David Marcos Halpern | Surgical instrument for biopsies |
US4200111A (en) * | 1978-09-21 | 1980-04-29 | Harris Arthur M | Specimen removal instrument |
US4201213A (en) * | 1978-01-30 | 1980-05-06 | Codman & Shurtleff, Inc. | Surgical tool |
US4283129A (en) * | 1979-08-03 | 1981-08-11 | Quality Craft, Inc. | Camera for recording the output of an instrument |
US4603694A (en) * | 1983-03-08 | 1986-08-05 | Richards Medical Company | Arthroscopic shaver |
US4682606A (en) * | 1986-02-03 | 1987-07-28 | Decaprio Vincent H | Localizing biopsy apparatus |
US4733663A (en) * | 1986-07-02 | 1988-03-29 | Farley Daniel K | Medical instrument for removing bone |
US4811734A (en) * | 1987-08-13 | 1989-03-14 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument |
US4834729A (en) * | 1986-12-30 | 1989-05-30 | Dyonics, Inc. | Arthroscopic surgical instrument |
US4844064A (en) * | 1987-09-30 | 1989-07-04 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument with end and side openings |
US4850354A (en) * | 1987-08-13 | 1989-07-25 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument |
US4911600A (en) * | 1984-01-20 | 1990-03-27 | Perkins Manufacturing Company | Lifting device |
US5026375A (en) * | 1989-10-25 | 1991-06-25 | Origin Medsystems, Inc. | Surgical cutting instrument |
US5040542A (en) * | 1990-03-05 | 1991-08-20 | Norman Gray | Bone biopsy needle |
US5108403A (en) * | 1990-11-09 | 1992-04-28 | Stern Mark S | Bone waxing device |
US5226910A (en) * | 1989-07-05 | 1993-07-13 | Kabushiki Kaisha Topcon | Surgical cutter |
US5281230A (en) * | 1991-05-02 | 1994-01-25 | Harald Heidmueller | Extractor |
US5290303A (en) * | 1990-06-22 | 1994-03-01 | Vance Products Incorporated D/B/A Cook Urological Incorporated | Surgical cutting instrument |
US5320110A (en) * | 1991-10-29 | 1994-06-14 | Wang Ko P | Pleural biopsy syringe-needles |
US5429138A (en) * | 1993-06-03 | 1995-07-04 | Kormed, Inc. | Biopsy needle with sample retaining means |
US5429136A (en) * | 1993-04-21 | 1995-07-04 | Devices For Vascular Intervention, Inc. | Imaging atherectomy apparatus |
US5531749A (en) * | 1993-06-10 | 1996-07-02 | Gary K. Michelson | Spinal bone waxer |
US5538008A (en) * | 1993-01-18 | 1996-07-23 | Crowe; John | Forceps for endoscopes |
US5540693A (en) * | 1992-02-12 | 1996-07-30 | Sierra Surgical, Inc. | Surgical instrument for cutting hard tissue and method of use |
US5595186A (en) * | 1992-04-06 | 1997-01-21 | Alan I. Rubinstein | Bone marrow biopsy needle |
US5613972A (en) * | 1992-07-15 | 1997-03-25 | The University Of Miami | Surgical cutting heads with curled cutting wings |
US5637096A (en) * | 1990-12-27 | 1997-06-10 | Yoon; Inbae | Safety needle |
US5638827A (en) * | 1994-02-01 | 1997-06-17 | Symbiosis Corporation | Super-elastic flexible jaws assembly for an endoscopic multiple sample bioptome |
US5645075A (en) * | 1992-02-18 | 1997-07-08 | Symbiosis Corporation | Jaw assembly for an endoscopic instrument |
US5649547A (en) * | 1994-03-24 | 1997-07-22 | Biopsys Medical, Inc. | Methods and devices for automated biopsy and collection of soft tissue |
US5705485A (en) * | 1987-09-18 | 1998-01-06 | Ethicon, Inc. | Gel formulations containing growth factors |
US5709697A (en) * | 1995-11-22 | 1998-01-20 | United States Surgical Corporation | Apparatus and method for removing tissue |
US5735865A (en) * | 1995-12-19 | 1998-04-07 | Richard Wolf Gmbh | Instrument for endoscopic therapy |
US5759185A (en) * | 1994-10-24 | 1998-06-02 | Smith & Nephew, Inc. | Surgical instrument |
US5775333A (en) * | 1994-03-24 | 1998-07-07 | Ethicon Endo-Surgery, Inc. | Apparatus for automated biopsy and collection of soft tissue |
US5776075A (en) * | 1996-08-09 | 1998-07-07 | Symbiosis Corporation | Endoscopic bioptome jaw assembly having three or more jaws and an endoscopic instrument incorporating same |
US5782849A (en) * | 1993-05-07 | 1998-07-21 | Sdgi Holdings, Inc. | Surgical cutting instrument |
US5792044A (en) * | 1996-03-22 | 1998-08-11 | Danek Medical, Inc. | Devices and methods for percutaneous surgery |
US5871453A (en) * | 1994-02-08 | 1999-02-16 | Boston Scientific Corporation | Moveable sample tube multiple biopsy sampling device |
US5873886A (en) * | 1995-04-04 | 1999-02-23 | United States Surgical Corporation | Surgical cutting apparatus |
US5879365A (en) * | 1995-04-04 | 1999-03-09 | United States Surgical Corporation | Surgical cutting apparatus |
US5879353A (en) * | 1995-01-17 | 1999-03-09 | Gore Enterprise Holdings, Inc. | Guided bone rasp |
US5925056A (en) * | 1996-04-12 | 1999-07-20 | Surgical Dynamics, Inc. | Surgical cutting device removably connected to a rotary drive element |
US5925050A (en) * | 1997-08-15 | 1999-07-20 | The University Of Iowa Research Foundation | Self-clearing bone biting instrument |
US6019765A (en) * | 1998-05-06 | 2000-02-01 | Johnson & Johnson Professional, Inc. | Morsellized bone allograft applicator device |
US6022362A (en) * | 1998-09-03 | 2000-02-08 | Rubicor Medical, Inc. | Excisional biopsy devices and methods |
US6083237A (en) * | 1998-10-23 | 2000-07-04 | Ethico Endo-Surgery, Inc. | Biopsy instrument with tissue penetrating spiral |
US6214010B1 (en) * | 1999-11-04 | 2001-04-10 | Thompson Surgical Instruments, Inc. | Rongeur surgical instrument |
US6221006B1 (en) * | 1998-02-10 | 2001-04-24 | Artemis Medical Inc. | Entrapping apparatus and method for use |
US20010005778A1 (en) * | 1999-12-22 | 2001-06-28 | Asahi Kogaku Kogyo Kabushiki Kaisha | Endoscopic tissue collecting instrument |
US6258093B1 (en) * | 1999-02-01 | 2001-07-10 | Garland U. Edwards | Surgical reamer cutter |
US6261294B1 (en) * | 1998-01-22 | 2001-07-17 | Karl Storz Gmbh & Co. Kg | Medical sliding-shaft instrument |
US6264087B1 (en) * | 1999-07-12 | 2001-07-24 | Powermed, Inc. | Expanding parallel jaw device for use with an electromechanical driver device |
US6375659B1 (en) * | 2001-02-20 | 2002-04-23 | Vita Licensing, Inc. | Method for delivery of biocompatible material |
US6419684B1 (en) * | 2000-05-16 | 2002-07-16 | Linvatec Corporation | End-cutting shaver blade for axial resection |
US20030009125A1 (en) * | 1991-01-11 | 2003-01-09 | Henry Nita | Ultrasonic devices and methods for ablating and removing obstructive matter from anatomical passageways and blood vessels |
US20030050574A1 (en) * | 2000-04-18 | 2003-03-13 | John Krueger | Bone biopsy instrument having improved sample retention |
US6533795B1 (en) * | 2000-04-11 | 2003-03-18 | Opus Medical, Inc | Dual function suturing apparatus and method |
US6575563B1 (en) * | 2002-08-05 | 2003-06-10 | Lexmark International, Inc. | Power/volume regime for ink jet printers |
US6575919B1 (en) * | 1999-10-19 | 2003-06-10 | Kyphon Inc. | Hand-held instruments that access interior body regions |
US6579291B1 (en) * | 2000-10-10 | 2003-06-17 | Spinalabs, Llc | Devices and methods for the treatment of spinal disorders |
US6682535B2 (en) * | 1999-06-16 | 2004-01-27 | Thomas Hoogland | Apparatus for decompressing herniated intervertebral discs |
US6692445B2 (en) * | 1999-07-27 | 2004-02-17 | Scimed Life Systems, Inc. | Biopsy sampler |
US20040049217A1 (en) * | 1996-06-07 | 2004-03-11 | Rod Ross | Apparatus and method for performing ophthalmic procedures |
US6716216B1 (en) * | 1998-08-14 | 2004-04-06 | Kyphon Inc. | Systems and methods for treating vertebral bodies |
US6746093B2 (en) * | 2001-06-08 | 2004-06-08 | Raul Martinez | Methods and apparatus for image transfer to non-planar surfaces |
US20040138701A1 (en) * | 1999-08-24 | 2004-07-15 | The Penn State Research Foundation | Laparoscopic surgical instrument and method |
US6852095B1 (en) * | 1997-07-09 | 2005-02-08 | Charles D. Ray | Interbody device and method for treatment of osteoporotic vertebral collapse |
US20050038432A1 (en) * | 2003-04-25 | 2005-02-17 | Shaolian Samuel M. | Articulating spinal fixation rod and system |
US20050070913A1 (en) * | 2003-09-29 | 2005-03-31 | Milbocker Michael T. | Devices and methods for spine repair |
US20050080441A1 (en) * | 2003-10-10 | 2005-04-14 | Duke University | Surgical instruments which are especially useful for ophthalmic surgical procedures, and methods of making the same |
US20050137602A1 (en) * | 2003-10-23 | 2005-06-23 | Assell Robert L. | Method and apparatus for spinal distraction |
US20050163850A1 (en) * | 2003-10-31 | 2005-07-28 | Wong Patrick S. | Administration of levodopa and carbidopa |
US20060030785A1 (en) * | 2004-05-11 | 2006-02-09 | Inrad, Inc. | Core biopsy device |
US20060036271A1 (en) * | 2004-07-29 | 2006-02-16 | X-Sten, Inc. | Spinal ligament modification devices |
US7008433B2 (en) * | 2001-02-15 | 2006-03-07 | Depuy Acromed, Inc. | Vertebroplasty injection device |
US7025771B2 (en) * | 2000-06-30 | 2006-04-11 | Spineology, Inc. | Tool to direct bone replacement material |
US7041050B1 (en) * | 2004-07-19 | 2006-05-09 | Ronald Medical Ltd. | System for performing a surgical procedure inside a body |
US20060122535A1 (en) * | 2004-12-08 | 2006-06-08 | Wolfgang Daum | Method and device to obtain percutaneous tissue samples |
US7066942B2 (en) * | 2002-10-03 | 2006-06-27 | Wright Medical Technology, Inc. | Bendable needle for delivering bone graft material and method of use |
US20070005084A1 (en) * | 2004-06-16 | 2007-01-04 | Clague Cynthia T | Minimally invasive coring vein harvester |
US7181289B2 (en) * | 2000-03-20 | 2007-02-20 | Pflueger D Russell | Epidural nerve root access catheter and treatment methods |
US20070055215A1 (en) * | 2005-07-29 | 2007-03-08 | X-Sten Corp. | Percutaneous Tissue Excision Devices and Methods |
US20070055263A1 (en) * | 2005-07-29 | 2007-03-08 | X-Sten Corp. | Tools for Percutaneous Spinal Ligament Decompression and Device for Supporting Same |
US7189206B2 (en) * | 2003-02-24 | 2007-03-13 | Senorx, Inc. | Biopsy device with inner cutter |
US7189240B1 (en) * | 1999-08-01 | 2007-03-13 | Disc-O-Tech Medical Technologies Ltd. | Method and apparatus for spinal procedures |
US20070123890A1 (en) * | 2005-11-04 | 2007-05-31 | X-Sten, Corp. | Tissue retrieval devices and methods |
US20070123888A1 (en) * | 2004-10-15 | 2007-05-31 | Baxano, Inc. | Flexible tissue rasp |
US20070162061A1 (en) * | 2005-11-04 | 2007-07-12 | X-Sten, Corp. | Tissue excision devices and methods |
US7322978B2 (en) * | 2004-06-22 | 2008-01-29 | Hs West Investments, Llc | Bone anchors for use in attaching soft tissue to a bone |
US7329402B2 (en) * | 1995-06-07 | 2008-02-12 | Imarx Pharmaceutical Corp. | Methods of imaging and treatment |
US20090118709A1 (en) * | 2007-11-06 | 2009-05-07 | Vertos Medical, Inc. A Delaware Corporation | Tissue Excision Tool, Kits and Methods of Using the Same |
Family Cites Families (157)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2670519A (en) | 1951-10-24 | 1954-03-02 | Charles F Recklitis | Drainage tube with clot extractor |
US3001522A (en) * | 1957-12-26 | 1961-09-26 | Silverman Irving | Biopsy device |
US3732858A (en) | 1968-09-16 | 1973-05-15 | Surgical Design Corp | Apparatus for removing blood clots, cataracts and other objects from the eye |
US3628524A (en) | 1969-02-28 | 1971-12-21 | Khosrow Jamshidi | Biopsy needle |
US3929123A (en) | 1973-02-07 | 1975-12-30 | Khosrow Jamshidi | Muscle biopsy needle |
US3945372A (en) | 1973-06-01 | 1976-03-23 | Milan Albert R | Medical tissue-obtaining system |
US4103690A (en) | 1977-03-21 | 1978-08-01 | Cordis Corporation | Self-suturing cardiac pacer lead |
US4174715A (en) | 1977-03-28 | 1979-11-20 | Hasson Harrith M | Multi-pronged laparoscopy forceps |
US6264617B1 (en) | 1977-09-12 | 2001-07-24 | Symbiosis Corporation | Radial jaw biopsy forceps |
US4535773A (en) | 1982-03-26 | 1985-08-20 | Inbae Yoon | Safety puncturing instrument and method |
US4522206A (en) * | 1983-01-26 | 1985-06-11 | Dyonics, Inc. | Surgical instrument |
US4777948A (en) | 1984-01-16 | 1988-10-18 | Wright David W | Surgical tool |
US4708147A (en) | 1985-02-25 | 1987-11-24 | Haaga John R | Universal biopsy needle |
GB8516230D0 (en) * | 1985-06-27 | 1985-07-31 | Ambrose B K | Tissue sampler |
US4801293A (en) | 1985-10-09 | 1989-01-31 | Anthony Jackson | Apparatus and method for detecting probe penetration of human epidural space and injecting a therapeutic substance thereinto |
US4931059A (en) | 1986-11-24 | 1990-06-05 | Markham Charles W | Needle/stylet combination |
GB8709021D0 (en) | 1987-04-15 | 1987-05-20 | Taylor J | Soft tissue biopsy device |
US4867157A (en) | 1987-08-13 | 1989-09-19 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument |
US5484437A (en) | 1988-06-13 | 1996-01-16 | Michelson; Gary K. | Apparatus and method of inserting spinal implants |
US4994072A (en) | 1988-08-31 | 1991-02-19 | Meadox Medicals, Inc. | Dilation catheter |
US5026386A (en) | 1988-12-23 | 1991-06-25 | Michelson Gary K | Flaval separator |
SE8900586L (en) | 1989-02-21 | 1990-08-22 | Pharmacia Ab | COMPOSITION AND PROCEDURES TO PREVENT ADHESION BETWEEN BODY TISSUE |
US5653713A (en) | 1989-04-24 | 1997-08-05 | Michelson; Gary Karlin | Surgical rongeur |
US5451227A (en) | 1989-04-24 | 1995-09-19 | Michaelson; Gary K. | Thin foot plate multi bite rongeur |
US5215105A (en) | 1989-11-14 | 1993-06-01 | Custom Medical Concepts, Inc. | Method of treating epidural lesions |
US5172702A (en) | 1989-11-24 | 1992-12-22 | Medical Device Technologies, Inc. | Disposable spring-loaded soft tissue biopsy apparatus |
US5797958A (en) | 1989-12-05 | 1998-08-25 | Yoon; Inbae | Endoscopic grasping instrument with scissors |
US5217473A (en) | 1989-12-05 | 1993-06-08 | Inbae Yoon | Multi-functional instruments and stretchable ligating and occluding devices |
US5797939A (en) * | 1989-12-05 | 1998-08-25 | Yoon; Inbae | Endoscopic scissors with longitudinal operating channel |
US5984939A (en) | 1989-12-05 | 1999-11-16 | Yoon; Inbae | Multifunctional grasping instrument with cutting member and operating channel for use in endoscopic and non-endoscopic procedures |
US5665100A (en) | 1989-12-05 | 1997-09-09 | Yoon; Inbae | Multifunctional instrument with interchangeable operating units for performing endoscopic procedures |
US5954739A (en) | 1990-03-02 | 1999-09-21 | General Surgical Innovations, Inc. | Method of dissecting tissue layers |
US5269785A (en) | 1990-06-28 | 1993-12-14 | Bonutti Peter M | Apparatus and method for tissue removal |
FR2666981B1 (en) | 1990-09-21 | 1993-06-25 | Commarmond Jacques | SYNTHETIC LIGAMENT VERTEBRAL. |
US5127916A (en) | 1991-01-22 | 1992-07-07 | Medical Device Technologies, Inc. | Localization needle assembly |
US5286255A (en) | 1991-07-29 | 1994-02-15 | Linvatec Corporation | Surgical forceps |
US5366477A (en) | 1991-10-17 | 1994-11-22 | American Cyanamid Company | Actuating forces transmission link and assembly for use in surgical instruments |
US5462062A (en) | 1991-12-13 | 1995-10-31 | Rubinstein; Daniel B. | Bone marrow biopsy needle with cutting and/or retaining device at distal end |
US5902272A (en) | 1992-01-07 | 1999-05-11 | Arthrocare Corporation | Planar ablation probe and method for electrosurgical cutting and ablation |
US5636639A (en) * | 1992-02-18 | 1997-06-10 | Symbiosis Corporation | Endoscopic multiple sample bioptome with enhanced biting action |
US5857996A (en) | 1992-07-06 | 1999-01-12 | Catheter Imaging Systems | Method of epidermal surgery |
US5354266A (en) | 1992-07-06 | 1994-10-11 | Catheter Imaging Systems | Method of epidural surgery |
US5514379A (en) | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
US5772597A (en) | 1992-09-14 | 1998-06-30 | Sextant Medical Corporation | Surgical tool end effector |
US5611354A (en) | 1992-11-12 | 1997-03-18 | Alleyne; Neville | Cardiac protection device |
US5417699A (en) | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5385570A (en) | 1993-01-12 | 1995-01-31 | R. J. Surgical Instruments, Inc. | Surgical cutting instrument |
US5439464A (en) | 1993-03-09 | 1995-08-08 | Shapiro Partners Limited | Method and instruments for performing arthroscopic spinal surgery |
CH685738A5 (en) * | 1993-03-25 | 1995-09-29 | Ferromec Sa | Medical instrument for removing deposits formed on the inner walls of the arteries or veins. |
US5300045A (en) | 1993-04-14 | 1994-04-05 | Plassche Jr Walter M | Interventional needle having an automatically capping stylet |
US6241747B1 (en) | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US5373854A (en) | 1993-07-15 | 1994-12-20 | Kolozsi; William Z. | Biopsy apparatus for use in endoscopy |
WO1995008945A2 (en) | 1993-09-20 | 1995-04-06 | Boston Scientific Corporation | Multiple biopsy sampling device |
US5487392A (en) | 1993-11-15 | 1996-01-30 | Haaga; John R. | Biopxy system with hemostatic insert |
DE4400409A1 (en) | 1994-01-05 | 1995-07-06 | Hein Kleihues | Microsurgical instrument |
NZ279442A (en) | 1994-01-26 | 1998-02-26 | Mark A Reiley | Bone treatment device; inflatable balloon for insertion into a bone; balloon details |
US5840338A (en) | 1994-07-18 | 1998-11-24 | Roos; Eric J. | Loading of biologically active solutes into polymer gels |
US5458112A (en) | 1994-08-15 | 1995-10-17 | Arrow Precision Products, Inc. | Biliary biopsy device |
US5569284A (en) | 1994-09-23 | 1996-10-29 | United States Surgical Corporation | Morcellator |
US5578030A (en) | 1994-11-04 | 1996-11-26 | Levin; John M. | Biopsy needle with cauterization feature |
US5562102A (en) | 1994-11-21 | 1996-10-08 | Taylor; Thomas V. | Multiple biopsy device |
US5562695A (en) | 1995-01-10 | 1996-10-08 | Obenchain; Theodore G. | Nerve deflecting conduit needle and method |
US6264650B1 (en) * | 1995-06-07 | 2001-07-24 | Arthrocare Corporation | Methods for electrosurgical treatment of intervertebral discs |
US6602248B1 (en) | 1995-06-07 | 2003-08-05 | Arthro Care Corp. | Methods for repairing damaged intervertebral discs |
US6772012B2 (en) | 1995-06-07 | 2004-08-03 | Arthrocare Corporation | Methods for electrosurgical treatment of spinal tissue |
US5681337A (en) | 1995-06-07 | 1997-10-28 | Bray Jr.; Robert S. | Bone shaver |
US5569258A (en) | 1995-06-22 | 1996-10-29 | Logan Instruments, Inc. | Laminectomy rongeurs |
US5782764A (en) | 1995-11-07 | 1998-07-21 | Iti Medical Technologies, Inc. | Fiber composite invasive medical instruments and methods for use in interventional imaging procedures |
US5827305A (en) | 1996-01-24 | 1998-10-27 | Gordon; Mark G. | Tissue sampling device |
US5985320A (en) | 1996-03-04 | 1999-11-16 | The Penn State Research Foundation | Materials and methods for enhancing cellular internalization |
EP1466564B1 (en) | 1996-03-22 | 2010-10-20 | Warsaw Orthopedic, Inc. | Devices for percutaneous surgery related applications |
US5823970A (en) | 1996-03-22 | 1998-10-20 | Medical Device Technologies, Inc. | Biopsy needle set |
US6679833B2 (en) | 1996-03-22 | 2004-01-20 | Sdgi Holdings, Inc. | Devices and methods for percutaneous surgery |
US6096053A (en) | 1996-05-03 | 2000-08-01 | Scimed Life Systems, Inc. | Medical retrieval basket |
EP1340467B1 (en) | 1996-05-09 | 2006-01-25 | Olympus Corporation | A cavity retaining tool for general surgery |
GB9609811D0 (en) | 1996-05-10 | 1996-07-17 | Web Dynamics Ltd | A process for producing meltblown polyolefin fibres for mechanical filtration |
US5853366A (en) | 1996-07-08 | 1998-12-29 | Kelsey, Inc. | Marker element for interstitial treatment and localizing device and method using same |
US7104986B2 (en) | 1996-07-16 | 2006-09-12 | Arthrocare Corporation | Intervertebral disc replacement method |
KR100207982B1 (en) | 1996-07-19 | 1999-07-15 | 윤종용 | Cleaner & cleaning method of metalmask for improving continuance of printing in surface mounting process |
AU5081298A (en) | 1996-10-15 | 1998-05-11 | R. John Hurlbert | Surgical method and composition therefor |
US6514256B2 (en) | 1997-01-02 | 2003-02-04 | St. Francis Medical Technologies, Inc. | Spine distraction implant and method |
US5836948A (en) | 1997-01-02 | 1998-11-17 | Saint Francis Medical Technologies, Llc | Spine distraction implant and method |
AU6604898A (en) * | 1997-03-13 | 1998-09-29 | Biomax Technologies, Inc. | Catheters and endoscopes comprising optical probes and bioptomes and methods of using the same |
US5931855A (en) | 1997-05-21 | 1999-08-03 | Frank Hoffman | Surgical methods using one-way suture |
US5964782A (en) | 1997-09-18 | 1999-10-12 | Scimed Life Systems, Inc. | Closure device and method |
US6050955A (en) | 1997-09-19 | 2000-04-18 | United States Surgical Corporation | Biopsy apparatus and method |
US5980525A (en) | 1997-10-27 | 1999-11-09 | Bristol-Myers Squibb Company | Bone reamer with impeller |
US5954747A (en) | 1997-11-20 | 1999-09-21 | Clark; Ron | Meniscus repair anchor system |
JPH11225951A (en) * | 1998-02-17 | 1999-08-24 | Olympus Optical Co Ltd | Treatment tool for endoscope |
US6428498B2 (en) | 1998-04-14 | 2002-08-06 | Renan Uflacker | Suction catheter for rapidly debriding abscesses |
CA2333121C (en) | 1998-05-21 | 2006-07-25 | Christopher J. Walshe | A tissue anchor system |
US6296639B1 (en) | 1999-02-12 | 2001-10-02 | Novacept | Apparatuses and methods for interstitial tissue removal |
US6139508A (en) * | 1998-08-04 | 2000-10-31 | Endonetics, Inc. | Articulated medical device |
US6605294B2 (en) | 1998-08-14 | 2003-08-12 | Incept Llc | Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels |
US6440147B1 (en) | 1998-09-03 | 2002-08-27 | Rubicor Medical, Inc. | Excisional biopsy devices and methods |
US6632182B1 (en) | 1998-10-23 | 2003-10-14 | The Trustees Of Columbia University In The City Of New York | Multiple bit, multiple specimen endoscopic biopsy forceps |
CA2287087C (en) | 1998-10-23 | 2007-12-04 | Ethicon Endo-Surgery, Inc. | Surgical device for the collection of soft tissue |
JP3708356B2 (en) | 1998-11-20 | 2005-10-19 | 株式会社モリタ製作所 | Tissue extractor and excision forceps used therefor |
US6530933B1 (en) | 1998-12-31 | 2003-03-11 | Teresa T. Yeung | Methods and devices for fastening bulging or herniated intervertebral discs |
ES2235828T3 (en) | 1999-02-03 | 2005-07-16 | Synthes Ag Chur | SURGICAL SCARIATOR. |
WO2000046868A1 (en) | 1999-02-04 | 2000-08-10 | Bolder Technologies Corporation | Lead-tin alloy current collectors, batteries made thereof and methods for manufacturing same |
AU2584199A (en) | 1999-02-05 | 2000-08-25 | Regents Of The University Of California, The | Thermo-reversible polymer for intralumenal implant |
US6478805B1 (en) | 1999-04-16 | 2002-11-12 | Nuvasive, Inc. | System for removing cut tissue from the inner bore of a surgical instrument |
US6858229B1 (en) | 1999-04-26 | 2005-02-22 | California Institute Of Technology | In situ forming hydrogels |
US6268405B1 (en) | 1999-05-04 | 2001-07-31 | Porex Surgical, Inc. | Hydrogels and methods of making and using same |
US6541020B1 (en) | 1999-07-09 | 2003-04-01 | Trimeris, Inc. | Methods and compositions for administration of therapeutic reagents |
US6638233B2 (en) | 1999-08-19 | 2003-10-28 | Fox Hollow Technologies, Inc. | Apparatus and methods for material capture and removal |
US6248081B1 (en) | 1999-09-28 | 2001-06-19 | Scimed Life Systems, Inc. | Endoscopic submucosal core biopsy device |
US6287304B1 (en) | 1999-10-15 | 2001-09-11 | Neothermia Corporation | Interstitial cauterization of tissue volumes with electrosurgically deployed electrodes |
US6358217B1 (en) | 2000-01-31 | 2002-03-19 | Hugh Bourassa | Automatic and semi-automatic disposable biopsy needle device |
US6558390B2 (en) | 2000-02-16 | 2003-05-06 | Axiamed, Inc. | Methods and apparatus for performing therapeutic procedures in the spine |
EP1267989B1 (en) | 2000-04-05 | 2006-07-19 | Pathway Medical Technologies, Inc. | Intralumenal material removal systems and methods |
US6443910B1 (en) | 2000-04-18 | 2002-09-03 | Allegiance Corporation | Bone marrow biopsy needle |
FR2808026B1 (en) | 2000-04-25 | 2002-06-14 | Alexandre Laurent | BIOMATERIAL BASED ON HYDROPHILIC POLYMER HAVING A SPECIFIC SIGNAL IN MAGNETIC RESONANCE IMAGING AND METHOD FOR PREPARING SUCH A BIOMATERIAL |
US6423332B1 (en) | 2000-05-26 | 2002-07-23 | Ethicon, Inc. | Method and composition for deforming soft tissues |
US6620185B1 (en) | 2000-06-27 | 2003-09-16 | Smith & Nephew, Inc. | Surgical procedures and instruments |
KR100889414B1 (en) | 2000-06-27 | 2009-03-20 | 키폰 에스에이알엘 | Systems and methods for injecting flowable materials into bones |
US20050075630A1 (en) | 2000-08-01 | 2005-04-07 | Dfine, Inc. | Voltage threshold ablation apparatus |
US7070596B1 (en) | 2000-08-09 | 2006-07-04 | Arthrocare Corporation | Electrosurgical apparatus having a curved distal section |
US6358254B1 (en) | 2000-09-11 | 2002-03-19 | D. Greg Anderson | Method and implant for expanding a spinal canal |
US6582447B1 (en) | 2000-10-20 | 2003-06-24 | Angiodynamics, Inc. | Convertible blood clot filter |
ES2238500T3 (en) | 2000-10-27 | 2005-09-01 | Sdgi Holdings, Inc. | RING REPAIR SYSTEM. |
US6987755B2 (en) | 2001-03-22 | 2006-01-17 | Siemens Communications, Inc. | System and method for user notification in a communication system |
WO2002096302A1 (en) | 2001-05-29 | 2002-12-05 | Microvention, Inc. | Method of manufacturing expansile filamentous embolization devices |
US6746451B2 (en) | 2001-06-01 | 2004-06-08 | Lance M. Middleton | Tissue cavitation device and method |
US6599310B2 (en) | 2001-06-29 | 2003-07-29 | Quill Medical, Inc. | Suture method |
FR2828088A1 (en) * | 2001-08-03 | 2003-02-07 | Artbois Sarl | Instrument to take sample of brain tissue, from brain cavity of sheep, has tube to be inserted through hole into cavity with extending tool structure of alignment arms and cutting tools |
US6669729B2 (en) | 2002-03-08 | 2003-12-30 | Kingsley Richard Chin | Apparatus and method for the replacement of posterior vertebral elements |
AU2003218189A1 (en) | 2002-03-18 | 2003-10-08 | American Osteomedix, Inc. | Minimally invasive bone manipulation device and method of use |
WO2003079907A1 (en) | 2002-03-20 | 2003-10-02 | Board Of Regents, The University Of Texas System | Biopsy needle |
US7118576B2 (en) | 2002-05-15 | 2006-10-10 | Nevmet Corporation | Multiportal device with linked cannulae and method for percutaneous surgery |
US6783534B2 (en) | 2002-07-29 | 2004-08-31 | Hamid M. Mehdizadeh | Bone wax applicator |
US7101382B2 (en) | 2002-11-12 | 2006-09-05 | Samuel George | Retractable scalpel |
US7985225B2 (en) | 2003-05-05 | 2011-07-26 | Alexandria Research Technologies, Llc | Apparatus and method for sculpting the surface of a joint |
KR100506543B1 (en) | 2003-08-14 | 2005-08-05 | 주식회사 제닉 | Temperature Sensitive State-Changing Hydrogel Composition and Method for their Preparation |
US20050197661A1 (en) | 2004-03-03 | 2005-09-08 | Scimed Life Systems, Inc. | Tissue removal probe with sliding burr in cutting window |
US20050209610A1 (en) | 2004-03-03 | 2005-09-22 | Scimed Life Systems, Inc. | Radially adjustable tissue removal device |
US20050228403A1 (en) | 2004-03-31 | 2005-10-13 | Manoa Medical, Inc., A Delaware Corporation | Tissue cutting devices and methods |
DE102004018872A1 (en) | 2004-04-19 | 2005-11-03 | Cervitech, Inc. | bone spreader |
US20050261692A1 (en) | 2004-05-21 | 2005-11-24 | Scimed Life Systems, Inc. | Articulating tissue removal probe and methods of using the same |
US7276032B2 (en) | 2004-09-29 | 2007-10-02 | Ethicon Endo-Surgery, Inc. | Biopsy apparatus and method |
WO2006044727A2 (en) | 2004-10-15 | 2006-04-27 | Baxano, Inc. | Devices and methods for tissue removal |
US20080147084A1 (en) | 2006-12-07 | 2008-06-19 | Baxano, Inc. | Tissue removal devices and methods |
US20080161809A1 (en) | 2006-10-03 | 2008-07-03 | Baxano, Inc. | Articulating Tissue Cutting Device |
US8221397B2 (en) * | 2004-10-15 | 2012-07-17 | Baxano, Inc. | Devices and methods for tissue modification |
US7938830B2 (en) | 2004-10-15 | 2011-05-10 | Baxano, Inc. | Powered tissue modification devices and methods |
US7738968B2 (en) | 2004-10-15 | 2010-06-15 | Baxano, Inc. | Devices and methods for selective surgical removal of tissue |
US20060122458A1 (en) | 2004-10-15 | 2006-06-08 | Baxano, Inc. | Devices and methods for tissue access |
US8109945B2 (en) | 2005-02-04 | 2012-02-07 | St. Jude Medical Puerto Rico Llc | Percutaneous suture path tracking device with cutting blade |
US20060206178A1 (en) | 2005-03-11 | 2006-09-14 | Kim Daniel H | Percutaneous endoscopic access tools for the spinal epidural space and related methods of treatment |
US20060224160A1 (en) * | 2005-04-01 | 2006-10-05 | Trieu Hai H | Instruments and methods for aggressive yet continuous tissue removal |
US8062298B2 (en) | 2005-10-15 | 2011-11-22 | Baxano, Inc. | Flexible tissue removal devices and methods |
WO2007085628A1 (en) | 2006-01-30 | 2007-08-02 | Zimmer Gmbh | Rongeur |
US8262661B2 (en) | 2006-04-05 | 2012-09-11 | Premia Spine Ltd. | Spinal reamer |
US7942830B2 (en) | 2006-05-09 | 2011-05-17 | Vertos Medical, Inc. | Ipsilateral approach to minimally invasive ligament decompression procedure |
WO2008139260A2 (en) | 2006-12-15 | 2008-11-20 | The Adelman Research Ltd. | Technique and device for laminar osteotomy and laminoplasty |
US20080221383A1 (en) | 2007-02-12 | 2008-09-11 | Vertos Medical, Inc. | Tissue excision devices and methods |
-
2006
- 2006-07-31 US US11/461,036 patent/US20070027464A1/en not_active Abandoned
- 2006-07-31 EP EP17166627.4A patent/EP3228265A3/en active Pending
- 2006-07-31 AT AT06800718T patent/ATE495701T1/en not_active IP Right Cessation
- 2006-07-31 DE DE602006019736T patent/DE602006019736D1/en active Active
- 2006-07-31 EP EP11150538.4A patent/EP2335600B1/en active Active
- 2006-07-31 ES ES11150538.4T patent/ES2637638T3/en active Active
- 2006-07-31 CA CA002614721A patent/CA2614721A1/en not_active Abandoned
- 2006-07-31 US US11/461,045 patent/US8696671B2/en active Active
- 2006-07-31 WO PCT/US2006/030298 patent/WO2007016683A2/en active Application Filing
- 2006-07-31 EP EP06800718A patent/EP1912575B1/en active Active
- 2006-07-31 JP JP2008524286A patent/JP2009502365A/en active Pending
- 2006-07-31 WO PCT/US2006/030302 patent/WO2007016686A2/en active Application Filing
-
2013
- 2013-09-05 US US14/019,135 patent/US8894653B2/en active Active
- 2013-09-20 US US14/032,770 patent/US8882772B2/en active Active
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1493240A (en) * | 1923-02-15 | 1924-05-06 | Frank J Bohn | Surgical bone cutter and extractor |
US3989033A (en) * | 1973-12-06 | 1976-11-02 | David Marcos Halpern | Surgical instrument for biopsies |
US3893445A (en) * | 1974-01-09 | 1975-07-08 | Becton Dickinson Co | Bone marrow biopsy instrument |
US4201213A (en) * | 1978-01-30 | 1980-05-06 | Codman & Shurtleff, Inc. | Surgical tool |
US4200111A (en) * | 1978-09-21 | 1980-04-29 | Harris Arthur M | Specimen removal instrument |
US4283129A (en) * | 1979-08-03 | 1981-08-11 | Quality Craft, Inc. | Camera for recording the output of an instrument |
US4603694A (en) * | 1983-03-08 | 1986-08-05 | Richards Medical Company | Arthroscopic shaver |
US4911600A (en) * | 1984-01-20 | 1990-03-27 | Perkins Manufacturing Company | Lifting device |
US4682606A (en) * | 1986-02-03 | 1987-07-28 | Decaprio Vincent H | Localizing biopsy apparatus |
US4733663A (en) * | 1986-07-02 | 1988-03-29 | Farley Daniel K | Medical instrument for removing bone |
US4834729A (en) * | 1986-12-30 | 1989-05-30 | Dyonics, Inc. | Arthroscopic surgical instrument |
US4850354A (en) * | 1987-08-13 | 1989-07-25 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument |
US4811734A (en) * | 1987-08-13 | 1989-03-14 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument |
US5705485A (en) * | 1987-09-18 | 1998-01-06 | Ethicon, Inc. | Gel formulations containing growth factors |
US4844064A (en) * | 1987-09-30 | 1989-07-04 | Baxter Travenol Laboratories, Inc. | Surgical cutting instrument with end and side openings |
US5226910A (en) * | 1989-07-05 | 1993-07-13 | Kabushiki Kaisha Topcon | Surgical cutter |
US5026375A (en) * | 1989-10-25 | 1991-06-25 | Origin Medsystems, Inc. | Surgical cutting instrument |
US5040542A (en) * | 1990-03-05 | 1991-08-20 | Norman Gray | Bone biopsy needle |
US5290303A (en) * | 1990-06-22 | 1994-03-01 | Vance Products Incorporated D/B/A Cook Urological Incorporated | Surgical cutting instrument |
US5108403A (en) * | 1990-11-09 | 1992-04-28 | Stern Mark S | Bone waxing device |
US5637096A (en) * | 1990-12-27 | 1997-06-10 | Yoon; Inbae | Safety needle |
US20030009125A1 (en) * | 1991-01-11 | 2003-01-09 | Henry Nita | Ultrasonic devices and methods for ablating and removing obstructive matter from anatomical passageways and blood vessels |
US5281230A (en) * | 1991-05-02 | 1994-01-25 | Harald Heidmueller | Extractor |
US5320110A (en) * | 1991-10-29 | 1994-06-14 | Wang Ko P | Pleural biopsy syringe-needles |
US5540693A (en) * | 1992-02-12 | 1996-07-30 | Sierra Surgical, Inc. | Surgical instrument for cutting hard tissue and method of use |
US5645075A (en) * | 1992-02-18 | 1997-07-08 | Symbiosis Corporation | Jaw assembly for an endoscopic instrument |
US5595186A (en) * | 1992-04-06 | 1997-01-21 | Alan I. Rubinstein | Bone marrow biopsy needle |
US5613972A (en) * | 1992-07-15 | 1997-03-25 | The University Of Miami | Surgical cutting heads with curled cutting wings |
US5538008A (en) * | 1993-01-18 | 1996-07-23 | Crowe; John | Forceps for endoscopes |
US5429136A (en) * | 1993-04-21 | 1995-07-04 | Devices For Vascular Intervention, Inc. | Imaging atherectomy apparatus |
US5782849A (en) * | 1993-05-07 | 1998-07-21 | Sdgi Holdings, Inc. | Surgical cutting instrument |
US5429138A (en) * | 1993-06-03 | 1995-07-04 | Kormed, Inc. | Biopsy needle with sample retaining means |
US5531749A (en) * | 1993-06-10 | 1996-07-02 | Gary K. Michelson | Spinal bone waxer |
US5638827A (en) * | 1994-02-01 | 1997-06-17 | Symbiosis Corporation | Super-elastic flexible jaws assembly for an endoscopic multiple sample bioptome |
US6053877A (en) * | 1994-02-08 | 2000-04-25 | Boston Scientific Corporation | Movable sample tube multiple biopsy sampling device |
US5871453A (en) * | 1994-02-08 | 1999-02-16 | Boston Scientific Corporation | Moveable sample tube multiple biopsy sampling device |
US5775333A (en) * | 1994-03-24 | 1998-07-07 | Ethicon Endo-Surgery, Inc. | Apparatus for automated biopsy and collection of soft tissue |
US7226424B2 (en) * | 1994-03-24 | 2007-06-05 | Ethicon Endo-Surgery, Inc. | Methods and devices for automated biopsy and collection of soft tissue |
US5649547A (en) * | 1994-03-24 | 1997-07-22 | Biopsys Medical, Inc. | Methods and devices for automated biopsy and collection of soft tissue |
US5759185A (en) * | 1994-10-24 | 1998-06-02 | Smith & Nephew, Inc. | Surgical instrument |
US5879353A (en) * | 1995-01-17 | 1999-03-09 | Gore Enterprise Holdings, Inc. | Guided bone rasp |
US5879365A (en) * | 1995-04-04 | 1999-03-09 | United States Surgical Corporation | Surgical cutting apparatus |
US5873886A (en) * | 1995-04-04 | 1999-02-23 | United States Surgical Corporation | Surgical cutting apparatus |
US7329402B2 (en) * | 1995-06-07 | 2008-02-12 | Imarx Pharmaceutical Corp. | Methods of imaging and treatment |
US5709697A (en) * | 1995-11-22 | 1998-01-20 | United States Surgical Corporation | Apparatus and method for removing tissue |
US5735865A (en) * | 1995-12-19 | 1998-04-07 | Richard Wolf Gmbh | Instrument for endoscopic therapy |
US5792044A (en) * | 1996-03-22 | 1998-08-11 | Danek Medical, Inc. | Devices and methods for percutaneous surgery |
US5925056A (en) * | 1996-04-12 | 1999-07-20 | Surgical Dynamics, Inc. | Surgical cutting device removably connected to a rotary drive element |
US20040049217A1 (en) * | 1996-06-07 | 2004-03-11 | Rod Ross | Apparatus and method for performing ophthalmic procedures |
US5776075A (en) * | 1996-08-09 | 1998-07-07 | Symbiosis Corporation | Endoscopic bioptome jaw assembly having three or more jaws and an endoscopic instrument incorporating same |
US6852095B1 (en) * | 1997-07-09 | 2005-02-08 | Charles D. Ray | Interbody device and method for treatment of osteoporotic vertebral collapse |
US5925050A (en) * | 1997-08-15 | 1999-07-20 | The University Of Iowa Research Foundation | Self-clearing bone biting instrument |
US6261294B1 (en) * | 1998-01-22 | 2001-07-17 | Karl Storz Gmbh & Co. Kg | Medical sliding-shaft instrument |
US6221006B1 (en) * | 1998-02-10 | 2001-04-24 | Artemis Medical Inc. | Entrapping apparatus and method for use |
US6019765A (en) * | 1998-05-06 | 2000-02-01 | Johnson & Johnson Professional, Inc. | Morsellized bone allograft applicator device |
US6716216B1 (en) * | 1998-08-14 | 2004-04-06 | Kyphon Inc. | Systems and methods for treating vertebral bodies |
US6022362A (en) * | 1998-09-03 | 2000-02-08 | Rubicor Medical, Inc. | Excisional biopsy devices and methods |
US6083237A (en) * | 1998-10-23 | 2000-07-04 | Ethico Endo-Surgery, Inc. | Biopsy instrument with tissue penetrating spiral |
US6258093B1 (en) * | 1999-02-01 | 2001-07-10 | Garland U. Edwards | Surgical reamer cutter |
US6682535B2 (en) * | 1999-06-16 | 2004-01-27 | Thomas Hoogland | Apparatus for decompressing herniated intervertebral discs |
US6264087B1 (en) * | 1999-07-12 | 2001-07-24 | Powermed, Inc. | Expanding parallel jaw device for use with an electromechanical driver device |
US6692445B2 (en) * | 1999-07-27 | 2004-02-17 | Scimed Life Systems, Inc. | Biopsy sampler |
US7189240B1 (en) * | 1999-08-01 | 2007-03-13 | Disc-O-Tech Medical Technologies Ltd. | Method and apparatus for spinal procedures |
US20040138701A1 (en) * | 1999-08-24 | 2004-07-15 | The Penn State Research Foundation | Laparoscopic surgical instrument and method |
US6575919B1 (en) * | 1999-10-19 | 2003-06-10 | Kyphon Inc. | Hand-held instruments that access interior body regions |
US6214010B1 (en) * | 1999-11-04 | 2001-04-10 | Thompson Surgical Instruments, Inc. | Rongeur surgical instrument |
US20010005778A1 (en) * | 1999-12-22 | 2001-06-28 | Asahi Kogaku Kogyo Kabushiki Kaisha | Endoscopic tissue collecting instrument |
US6572563B2 (en) * | 1999-12-22 | 2003-06-03 | Pentax Corporation | Endoscopic tissue collecting instrument |
US7181289B2 (en) * | 2000-03-20 | 2007-02-20 | Pflueger D Russell | Epidural nerve root access catheter and treatment methods |
US6533795B1 (en) * | 2000-04-11 | 2003-03-18 | Opus Medical, Inc | Dual function suturing apparatus and method |
US20030050574A1 (en) * | 2000-04-18 | 2003-03-13 | John Krueger | Bone biopsy instrument having improved sample retention |
US7201722B2 (en) * | 2000-04-18 | 2007-04-10 | Allegiance Corporation | Bone biopsy instrument having improved sample retention |
US6419684B1 (en) * | 2000-05-16 | 2002-07-16 | Linvatec Corporation | End-cutting shaver blade for axial resection |
US7025771B2 (en) * | 2000-06-30 | 2006-04-11 | Spineology, Inc. | Tool to direct bone replacement material |
US6579291B1 (en) * | 2000-10-10 | 2003-06-17 | Spinalabs, Llc | Devices and methods for the treatment of spinal disorders |
US7008433B2 (en) * | 2001-02-15 | 2006-03-07 | Depuy Acromed, Inc. | Vertebroplasty injection device |
US6375659B1 (en) * | 2001-02-20 | 2002-04-23 | Vita Licensing, Inc. | Method for delivery of biocompatible material |
US6746093B2 (en) * | 2001-06-08 | 2004-06-08 | Raul Martinez | Methods and apparatus for image transfer to non-planar surfaces |
US6575563B1 (en) * | 2002-08-05 | 2003-06-10 | Lexmark International, Inc. | Power/volume regime for ink jet printers |
US7066942B2 (en) * | 2002-10-03 | 2006-06-27 | Wright Medical Technology, Inc. | Bendable needle for delivering bone graft material and method of use |
US7189206B2 (en) * | 2003-02-24 | 2007-03-13 | Senorx, Inc. | Biopsy device with inner cutter |
US20050038432A1 (en) * | 2003-04-25 | 2005-02-17 | Shaolian Samuel M. | Articulating spinal fixation rod and system |
US20050070913A1 (en) * | 2003-09-29 | 2005-03-31 | Milbocker Michael T. | Devices and methods for spine repair |
US20050080441A1 (en) * | 2003-10-10 | 2005-04-14 | Duke University | Surgical instruments which are especially useful for ophthalmic surgical procedures, and methods of making the same |
US20050137602A1 (en) * | 2003-10-23 | 2005-06-23 | Assell Robert L. | Method and apparatus for spinal distraction |
US20050163850A1 (en) * | 2003-10-31 | 2005-07-28 | Wong Patrick S. | Administration of levodopa and carbidopa |
US20060030785A1 (en) * | 2004-05-11 | 2006-02-09 | Inrad, Inc. | Core biopsy device |
US20070005084A1 (en) * | 2004-06-16 | 2007-01-04 | Clague Cynthia T | Minimally invasive coring vein harvester |
US7322978B2 (en) * | 2004-06-22 | 2008-01-29 | Hs West Investments, Llc | Bone anchors for use in attaching soft tissue to a bone |
US7041050B1 (en) * | 2004-07-19 | 2006-05-09 | Ronald Medical Ltd. | System for performing a surgical procedure inside a body |
US20060036211A1 (en) * | 2004-07-29 | 2006-02-16 | X-Sten, Inc. | Spinal ligament modification kit |
US20060036271A1 (en) * | 2004-07-29 | 2006-02-16 | X-Sten, Inc. | Spinal ligament modification devices |
US20070123888A1 (en) * | 2004-10-15 | 2007-05-31 | Baxano, Inc. | Flexible tissue rasp |
US20060122535A1 (en) * | 2004-12-08 | 2006-06-08 | Wolfgang Daum | Method and device to obtain percutaneous tissue samples |
US20070055215A1 (en) * | 2005-07-29 | 2007-03-08 | X-Sten Corp. | Percutaneous Tissue Excision Devices and Methods |
US20070055263A1 (en) * | 2005-07-29 | 2007-03-08 | X-Sten Corp. | Tools for Percutaneous Spinal Ligament Decompression and Device for Supporting Same |
US20070123890A1 (en) * | 2005-11-04 | 2007-05-31 | X-Sten, Corp. | Tissue retrieval devices and methods |
US20070162061A1 (en) * | 2005-11-04 | 2007-07-12 | X-Sten, Corp. | Tissue excision devices and methods |
US20090118709A1 (en) * | 2007-11-06 | 2009-05-07 | Vertos Medical, Inc. A Delaware Corporation | Tissue Excision Tool, Kits and Methods of Using the Same |
Cited By (118)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040267269A1 (en) * | 2001-06-01 | 2004-12-30 | Middleton Lance M. | Tissue cavitation device and method |
US8142462B2 (en) | 2004-05-28 | 2012-03-27 | Cavitech, Llc | Instruments and methods for reducing and stabilizing bone fractures |
US8562634B2 (en) | 2004-05-28 | 2013-10-22 | Cavitech, Llc | Instruments and methods for reducing and stabilizing bone fractures |
US20060036272A1 (en) * | 2004-07-29 | 2006-02-16 | X-Sten, Inc. | Spinal ligament modification |
US20060036271A1 (en) * | 2004-07-29 | 2006-02-16 | X-Sten, Inc. | Spinal ligament modification devices |
US20060036211A1 (en) * | 2004-07-29 | 2006-02-16 | X-Sten, Inc. | Spinal ligament modification kit |
US20060184175A1 (en) * | 2004-07-29 | 2006-08-17 | X-Sten, Inc. | Spinal ligament modification devices |
US20060206115A1 (en) * | 2004-07-29 | 2006-09-14 | X-Sten | Ligament decompression kit with contrast |
US20060235451A1 (en) * | 2004-07-29 | 2006-10-19 | X-Sten | Ligament Decompression Tool with Tissue Engaging Device |
US20060235452A1 (en) * | 2004-07-29 | 2006-10-19 | X-Sten | Ligament Decompression Tool with Tissue Removal Device |
US20060264994A1 (en) * | 2004-07-29 | 2006-11-23 | X-Sten | Spinal Decompression Method Using Tissue Retraction |
US7896879B2 (en) | 2004-07-29 | 2011-03-01 | Vertos Medical, Inc. | Spinal ligament modification |
US9456829B2 (en) | 2004-10-15 | 2016-10-04 | Amendia, Inc. | Powered tissue modification devices and methods |
US9247952B2 (en) | 2004-10-15 | 2016-02-02 | Amendia, Inc. | Devices and methods for tissue access |
US20070213735A1 (en) * | 2004-10-15 | 2007-09-13 | Vahid Saadat | Powered tissue modification devices and methods |
US7938830B2 (en) | 2004-10-15 | 2011-05-10 | Baxano, Inc. | Powered tissue modification devices and methods |
US11382647B2 (en) | 2004-10-15 | 2022-07-12 | Spinal Elements, Inc. | Devices and methods for treating tissue |
US10052116B2 (en) | 2004-10-15 | 2018-08-21 | Amendia, Inc. | Devices and methods for treating tissue |
US20110098708A9 (en) * | 2004-10-15 | 2011-04-28 | Vahid Saadat | Powered tissue modification devices and methods |
US9463041B2 (en) | 2004-10-15 | 2016-10-11 | Amendia, Inc. | Devices and methods for tissue access |
US8579902B2 (en) | 2004-10-15 | 2013-11-12 | Baxano Signal, Inc. | Devices and methods for tissue modification |
US8257356B2 (en) | 2004-10-15 | 2012-09-04 | Baxano, Inc. | Guidewire exchange systems to treat spinal stenosis |
US9345491B2 (en) | 2004-10-15 | 2016-05-24 | Amendia, Inc. | Flexible tissue rasp |
US9320618B2 (en) | 2004-10-15 | 2016-04-26 | Amendia, Inc. | Access and tissue modification systems and methods |
US20080275458A1 (en) * | 2004-10-15 | 2008-11-06 | Bleich Jeffery L | Guidewire exchange systems to treat spinal stenosis |
US20110160731A1 (en) * | 2004-10-15 | 2011-06-30 | Bleich Jeffery L | Devices and methods for tissue access |
US20110224710A1 (en) * | 2004-10-15 | 2011-09-15 | Bleich Jeffery L | Methods, systems and devices for carpal tunnel release |
US9101386B2 (en) | 2004-10-15 | 2015-08-11 | Amendia, Inc. | Devices and methods for treating tissue |
US8568416B2 (en) | 2004-10-15 | 2013-10-29 | Baxano Surgical, Inc. | Access and tissue modification systems and methods |
US20100331883A1 (en) * | 2004-10-15 | 2010-12-30 | Schmitz Gregory P | Access and tissue modification systems and methods |
US8801626B2 (en) | 2004-10-15 | 2014-08-12 | Baxano Surgical, Inc. | Flexible neural localization devices and methods |
US8048080B2 (en) | 2004-10-15 | 2011-11-01 | Baxano, Inc. | Flexible tissue rasp |
US8430881B2 (en) | 2004-10-15 | 2013-04-30 | Baxano, Inc. | Mechanical tissue modification devices and methods |
US8652138B2 (en) | 2004-10-15 | 2014-02-18 | Baxano Surgical, Inc. | Flexible tissue rasp |
US8613745B2 (en) | 2004-10-15 | 2013-12-24 | Baxano Surgical, Inc. | Methods, systems and devices for carpal tunnel release |
US8617163B2 (en) | 2004-10-15 | 2013-12-31 | Baxano Surgical, Inc. | Methods, systems and devices for carpal tunnel release |
US8647346B2 (en) | 2004-10-15 | 2014-02-11 | Baxano Surgical, Inc. | Devices and methods for tissue modification |
US20100010334A1 (en) * | 2005-05-16 | 2010-01-14 | Bleich Jeffery L | Spinal access and neural localization |
US20060258951A1 (en) * | 2005-05-16 | 2006-11-16 | Baxano, Inc. | Spinal Access and Neural Localization |
US8419653B2 (en) | 2005-05-16 | 2013-04-16 | Baxano, Inc. | Spinal access and neural localization |
US8894653B2 (en) | 2005-07-29 | 2014-11-25 | Vertos Medical, Inc. | Percutaneous tissue excision devices and methods |
US20070055215A1 (en) * | 2005-07-29 | 2007-03-08 | X-Sten Corp. | Percutaneous Tissue Excision Devices and Methods |
US20070055263A1 (en) * | 2005-07-29 | 2007-03-08 | X-Sten Corp. | Tools for Percutaneous Spinal Ligament Decompression and Device for Supporting Same |
US8696671B2 (en) | 2005-07-29 | 2014-04-15 | Vertos Medical Inc. | Percutaneous tissue excision devices |
US8882772B2 (en) | 2005-07-29 | 2014-11-11 | Vertos Medical, Inc. | Percutaneous tissue excision devices and methods |
US8366712B2 (en) | 2005-10-15 | 2013-02-05 | Baxano, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US7887538B2 (en) | 2005-10-15 | 2011-02-15 | Baxano, Inc. | Methods and apparatus for tissue modification |
US8062298B2 (en) | 2005-10-15 | 2011-11-22 | Baxano, Inc. | Flexible tissue removal devices and methods |
US9125682B2 (en) | 2005-10-15 | 2015-09-08 | Amendia, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US20090177241A1 (en) * | 2005-10-15 | 2009-07-09 | Bleich Jeffery L | Multiple pathways for spinal nerve root decompression from a single access point |
US9492151B2 (en) | 2005-10-15 | 2016-11-15 | Amendia, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US8092456B2 (en) | 2005-10-15 | 2012-01-10 | Baxano, Inc. | Multiple pathways for spinal nerve root decompression from a single access point |
US20070123890A1 (en) * | 2005-11-04 | 2007-05-31 | X-Sten, Corp. | Tissue retrieval devices and methods |
US20070123877A1 (en) * | 2005-11-15 | 2007-05-31 | Aoi Medical, Inc. | Inflatable Device for Restoring Anatomy of Fractured Bone |
US8062300B2 (en) | 2006-05-04 | 2011-11-22 | Baxano, Inc. | Tissue removal with at least partially flexible devices |
US20070260252A1 (en) * | 2006-05-04 | 2007-11-08 | Baxano, Inc. | Tissue Removal with at Least Partially Flexible Devices |
US9351741B2 (en) | 2006-05-04 | 2016-05-31 | Amendia, Inc. | Flexible tissue removal devices and methods |
US8585704B2 (en) | 2006-05-04 | 2013-11-19 | Baxano Surgical, Inc. | Flexible tissue removal devices and methods |
US8734477B2 (en) | 2006-05-09 | 2014-05-27 | Vertos Medical, Inc. | Translaminar approach to minimally invasive ligament decompression procedure |
US20090036936A1 (en) * | 2006-05-09 | 2009-02-05 | Vertos Medical, Inc. | Translaminar approach to minimally invasive ligament decompression procedure |
US7942830B2 (en) | 2006-05-09 | 2011-05-17 | Vertos Medical, Inc. | Ipsilateral approach to minimally invasive ligament decompression procedure |
US20070276390A1 (en) * | 2006-05-09 | 2007-11-29 | X-Sten, Inc. | Ipsilateral Approach to Minimally Invasive Ligament Decompression Procedure |
US8608762B2 (en) | 2006-05-09 | 2013-12-17 | Vertos Medical, Inc. | Translaminar approach to minimally invasive ligament decompression procedure |
USD620593S1 (en) | 2006-07-31 | 2010-07-27 | Vertos Medical, Inc. | Tissue excision device |
US20080033465A1 (en) * | 2006-08-01 | 2008-02-07 | Baxano, Inc. | Multi-Wire Tissue Cutter |
US20080091227A1 (en) * | 2006-08-25 | 2008-04-17 | Baxano, Inc. | Surgical probe and method of making |
US8845637B2 (en) | 2006-08-29 | 2014-09-30 | Baxano Surgical, Inc. | Tissue access guidewire system and method |
US20110046613A1 (en) * | 2006-08-29 | 2011-02-24 | Gregory Schmitz | Tissue access guidewire system and method |
US8551097B2 (en) | 2006-08-29 | 2013-10-08 | Baxano Surgical, Inc. | Tissue access guidewire system and method |
US20080086034A1 (en) * | 2006-08-29 | 2008-04-10 | Baxano, Inc. | Tissue Access Guidewire System and Method |
US7857813B2 (en) | 2006-08-29 | 2010-12-28 | Baxano, Inc. | Tissue access guidewire system and method |
US20080161809A1 (en) * | 2006-10-03 | 2008-07-03 | Baxano, Inc. | Articulating Tissue Cutting Device |
US20080111101A1 (en) * | 2006-11-09 | 2008-05-15 | Jason Keleher | Compositions and methods for CMP of low-k-dielectric materials |
US20080147084A1 (en) * | 2006-12-07 | 2008-06-19 | Baxano, Inc. | Tissue removal devices and methods |
US20080221383A1 (en) * | 2007-02-12 | 2008-09-11 | Vertos Medical, Inc. | Tissue excision devices and methods |
US20080294166A1 (en) * | 2007-05-21 | 2008-11-27 | Mark Goldin | Extendable cutting member |
US20080294167A1 (en) * | 2007-05-21 | 2008-11-27 | Brian Schumacher | Articulating cavitation device |
US20090131952A1 (en) * | 2007-05-21 | 2009-05-21 | Brian Schumacher | Delivery system and method for inflatable devices |
US8353911B2 (en) | 2007-05-21 | 2013-01-15 | Aoi Medical, Inc. | Extendable cutting member |
US20080312660A1 (en) * | 2007-06-15 | 2008-12-18 | Baxano, Inc. | Devices and methods for measuring the space around a nerve root |
US20090018507A1 (en) * | 2007-07-09 | 2009-01-15 | Baxano, Inc. | Spinal access system and method |
US8303516B2 (en) | 2007-09-06 | 2012-11-06 | Baxano, Inc. | Method, system and apparatus for neural localization |
US7959577B2 (en) | 2007-09-06 | 2011-06-14 | Baxano, Inc. | Method, system, and apparatus for neural localization |
US20090118709A1 (en) * | 2007-11-06 | 2009-05-07 | Vertos Medical, Inc. A Delaware Corporation | Tissue Excision Tool, Kits and Methods of Using the Same |
US20100321426A1 (en) * | 2007-11-22 | 2010-12-23 | Kazuki Suzuki | Image forming apparatus |
US8192436B2 (en) | 2007-12-07 | 2012-06-05 | Baxano, Inc. | Tissue modification devices |
US20090149865A1 (en) * | 2007-12-07 | 2009-06-11 | Schmitz Gregory P | Tissue modification devices |
US9463029B2 (en) | 2007-12-07 | 2016-10-11 | Amendia, Inc. | Tissue modification devices |
US8663228B2 (en) | 2007-12-07 | 2014-03-04 | Baxano Surgical, Inc. | Tissue modification devices |
US20090171381A1 (en) * | 2007-12-28 | 2009-07-02 | Schmitz Gregory P | Devices, methods and systems for neural localization |
US8398641B2 (en) | 2008-07-01 | 2013-03-19 | Baxano, Inc. | Tissue modification devices and methods |
US8409206B2 (en) | 2008-07-01 | 2013-04-02 | Baxano, Inc. | Tissue modification devices and methods |
US9314253B2 (en) | 2008-07-01 | 2016-04-19 | Amendia, Inc. | Tissue modification devices and methods |
US20110112539A1 (en) * | 2008-07-14 | 2011-05-12 | Wallace Michael P | Tissue modification devices |
US8845639B2 (en) | 2008-07-14 | 2014-09-30 | Baxano Surgical, Inc. | Tissue modification devices |
USD619253S1 (en) | 2008-10-23 | 2010-07-06 | Vertos Medical, Inc. | Tissue modification device |
USD621939S1 (en) | 2008-10-23 | 2010-08-17 | Vertos Medical, Inc. | Tissue modification device |
USD676964S1 (en) | 2008-10-23 | 2013-02-26 | Vertos Medical, Inc. | Tissue modification device |
USD619252S1 (en) | 2008-10-23 | 2010-07-06 | Vertos Medical, Inc. | Tissue modification device |
USD611146S1 (en) | 2008-10-23 | 2010-03-02 | Vertos Medical, Inc. | Tissue modification device |
USD610259S1 (en) | 2008-10-23 | 2010-02-16 | Vertos Medical, Inc. | Tissue modification device |
USD635671S1 (en) | 2008-10-23 | 2011-04-05 | Vertos Medical, Inc. | Tissue modification device |
US8221420B2 (en) | 2009-02-16 | 2012-07-17 | Aoi Medical, Inc. | Trauma nail accumulator |
US8394102B2 (en) | 2009-06-25 | 2013-03-12 | Baxano, Inc. | Surgical tools for treatment of spinal stenosis |
US20100331900A1 (en) * | 2009-06-25 | 2010-12-30 | Baxano, Inc. | Surgical tools for treatment of spinal stenosis |
US9414884B2 (en) | 2011-07-22 | 2016-08-16 | Martin Faehndrich | Instrument set for treating stenoses of the spinal canal |
US9161774B2 (en) * | 2013-03-14 | 2015-10-20 | Kyphon Sarl | Rotatable cutting instrument |
US20140276802A1 (en) * | 2013-03-14 | 2014-09-18 | Kyphon Sarl | Rotatable cutting instrument and method |
US11064981B2 (en) | 2013-08-31 | 2021-07-20 | Merit Medical Systems, Inc. | Tissue removal device and method of use |
EP3038548A4 (en) * | 2013-08-31 | 2017-08-23 | Robert Peliks | Tissue removal device and method of use |
US9763648B2 (en) | 2013-08-31 | 2017-09-19 | Becton, Dickerson and Company | Tissue removal device and method of use |
WO2016154030A1 (en) * | 2015-03-20 | 2016-09-29 | Musc Foundation For Research Development | Dural protecting rongeur |
US11701231B2 (en) * | 2015-04-14 | 2023-07-18 | Cartiva, Inc. | Tooling for creating tapered opening in tissue and related methods |
US20210212832A1 (en) * | 2015-04-14 | 2021-07-15 | Cartiva, Inc. | Tooling for creating tapered opening in tissue and related methods |
US20180014837A1 (en) * | 2016-07-13 | 2018-01-18 | Washington University | Discectomy instrument |
US10743891B2 (en) * | 2016-07-13 | 2020-08-18 | Washington University | Discectomy instrument |
CN106137268A (en) * | 2016-08-26 | 2016-11-23 | 南京微创医学科技股份有限公司 | A kind of ultrasonic sampling probe |
WO2022244711A1 (en) * | 2021-05-18 | 2022-11-24 | オリンパス株式会社 | Biopsy device and specimen sampling device |
Also Published As
Publication number | Publication date |
---|---|
ATE495701T1 (en) | 2011-02-15 |
WO2007016686A3 (en) | 2009-05-07 |
ES2637638T3 (en) | 2017-10-16 |
EP3228265A2 (en) | 2017-10-11 |
US20070055215A1 (en) | 2007-03-08 |
US8696671B2 (en) | 2014-04-15 |
EP2335600B1 (en) | 2017-04-19 |
CA2614721A1 (en) | 2007-02-08 |
WO2007016686A2 (en) | 2007-02-08 |
US8882772B2 (en) | 2014-11-11 |
DE602006019736D1 (en) | 2011-03-03 |
US8894653B2 (en) | 2014-11-25 |
EP1912575A2 (en) | 2008-04-23 |
EP1912575A4 (en) | 2009-11-25 |
US20140005671A1 (en) | 2014-01-02 |
US20140024933A1 (en) | 2014-01-23 |
WO2007016683A3 (en) | 2009-05-07 |
EP1912575B1 (en) | 2011-01-19 |
WO2007016683A2 (en) | 2007-02-08 |
EP2335600A1 (en) | 2011-06-22 |
JP2009502365A (en) | 2009-01-29 |
EP3228265A3 (en) | 2018-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070027464A1 (en) | Device for resecting spinal tissue | |
CA2574977C (en) | Spinal ligament modification devices | |
US8734477B2 (en) | Translaminar approach to minimally invasive ligament decompression procedure | |
US20070055263A1 (en) | Tools for Percutaneous Spinal Ligament Decompression and Device for Supporting Same | |
US20070162061A1 (en) | Tissue excision devices and methods | |
US20070123890A1 (en) | Tissue retrieval devices and methods | |
US20090143807A1 (en) | Percutaneous Devices for Separating Tissue, Kits and Methods of Using the Same | |
US20090118709A1 (en) | Tissue Excision Tool, Kits and Methods of Using the Same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: X-STEN, CORP., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SCHOMER, DONALD;SOLSBERG, MURRAY D.;REEL/FRAME:018368/0507;SIGNING DATES FROM 20060822 TO 20060828 Owner name: X-STEN, CORP., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WAY, BRYCE;REEL/FRAME:018368/0467 Effective date: 20060906 |
|
AS | Assignment |
Owner name: VERTOS MEDICAL, INC., CALIFORNIA Free format text: CHANGE OF NAME;ASSIGNOR:X-STEN CORP;REEL/FRAME:020185/0620 Effective date: 20070817 |
|
AS | Assignment |
Owner name: X-STEN CORP, CALIFORNIA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 018368 FRAME 0507;ASSIGNOR:SCHOMER, DONALD;REEL/FRAME:021633/0682 Effective date: 20060828 Owner name: X-STEN CORP, CALIFORNIA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 018368 FRAME 0507;ASSIGNOR:SOLSBERG, MURRAY D.;REEL/FRAME:021633/0706 Effective date: 20080822 Owner name: X-STEN CORP, CALIFORNIA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 018368 FRAME 0467;ASSIGNOR:WAY, BRYCE;REEL/FRAME:021633/0718 Effective date: 20060906 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |